ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-5619102,SLC transporter disorders,2/12,98/10899,0.004980854893975673,0.10259705090767954,0.06635953831695189,SLC3A2/SLC20A2,2
R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,2/12,108/10899,0.0060180836945068405,0.10259705090767954,0.06635953831695189,SLC3A2/SLC20A2,2
R-HSA-166520,Signaling by NTRKs,2/12,134/10899,0.009134913068399435,0.10259705090767954,0.06635953831695189,PCSK5/IRS2,2
R-HSA-74749,Signal attenuation,1/12,10/10899,0.010960297070206515,0.10259705090767954,0.06635953831695189,IRS2,1
R-HSA-2586552,Signaling by Leptin,1/12,11/10899,0.012050248069853886,0.10259705090767954,0.06635953831695189,IRS2,1
R-HSA-9027276,Erythropoietin activates Phosphoinositide-3-kinase (PI3K),1/12,12/10899,0.013139097906661346,0.10259705090767954,0.06635953831695189,IRS2,1
R-HSA-2168880,Scavenging of heme from plasma,1/12,13/10899,0.014226847592076708,0.10259705090767954,0.06635953831695189,LRP1,1
R-HSA-75035,Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,1/12,13/10899,0.014226847592076708,0.10259705090767954,0.06635953831695189,WEE1,1
R-HSA-71240,Tryptophan catabolism,1/12,14/10899,0.015313498136711678,0.10259705090767954,0.06635953831695189,SLC3A2,1
R-HSA-8964539,Glutamate and glutamine metabolism,1/12,14/10899,0.015313498136711678,0.10259705090767954,0.06635953831695189,GLUL,1
R-HSA-9027284,Erythropoietin activates RAS,1/12,14/10899,0.015313498136711678,0.10259705090767954,0.06635953831695189,IRS2,1
R-HSA-5619115,Disorders of transmembrane transporters,2/12,176/10899,0.015386944615640611,0.10259705090767954,0.06635953831695189,SLC3A2/SLC20A2,2
R-HSA-156711,Polo-like kinase mediated events,1/12,16/10899,0.0174835058419065,0.10259705090767954,0.06635953831695189,WEE1,1
R-HSA-6788467,IL-6-type cytokine receptor ligand interactions,1/12,17/10899,0.018566865019513767,0.10259705090767954,0.06635953831695189,CLCF1,1
R-HSA-8963889,Assembly of active LPL and LIPC lipase complexes,1/12,19/10899,0.02073029906110979,0.10259705090767954,0.06635953831695189,PCSK5,1
R-HSA-2022870,Chondroitin sulfate biosynthesis,1/12,20/10899,0.021810375937145632,0.10259705090767954,0.06635953831695189,CHSY1,1
R-HSA-373753,Nephrin family interactions,1/12,23/10899,0.025044058041009065,0.10259705090767954,0.06635953831695189,ACTN4,1
R-HSA-6783589,Interleukin-6 family signaling,1/12,24/10899,0.02611977257792586,0.10259705090767954,0.06635953831695189,CLCF1,1
R-HSA-982772,Growth hormone receptor signaling,1/12,24/10899,0.02611977257792586,0.10259705090767954,0.06635953831695189,IRS2,1
R-HSA-210991,Basigin interactions,1/12,25/10899,0.027194399035770478,0.10259705090767954,0.06635953831695189,SLC3A2,1
R-HSA-69273,Cyclin A/B1/B2 associated events during G2/M transition,1/12,25/10899,0.027194399035770478,0.10259705090767954,0.06635953831695189,WEE1,1
R-HSA-9006335,Signaling by Erythropoietin,1/12,25/10899,0.027194399035770478,0.10259705090767954,0.06635953831695189,IRS2,1
R-HSA-425407,SLC-mediated transmembrane transport,2/12,250/10899,0.029724626514373485,0.10726713046491301,0.06938013511364063,SLC3A2/SLC20A2,2
R-HSA-3000157,Laminin interactions,1/12,30/10899,0.032551245131799744,0.11257305608080745,0.07281199568955206,ITGA7,1
R-HSA-352230,Amino acid transport across the plasma membrane,1/12,33/10899,0.0357523597531042,0.1141325330579865,0.0738206618383933,SLC3A2,1
R-HSA-8963899,Plasma lipoprotein remodeling,1/12,33/10899,0.0357523597531042,0.1141325330579865,0.0738206618383933,PCSK5,1
R-HSA-1266695,Interleukin-7 signaling,1/12,36/10899,0.03894376244051134,0.11971601046527561,0.07743204227937928,IRS2,1
R-HSA-8853659,RET signaling,1/12,40/10899,0.04318390487199997,0.12296162767353594,0.07953130008053688,IRS2,1
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,1/12,41/10899,0.04424125758786146,0.12296162767353594,0.07953130008053688,CHSY1,1
R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,1/12,42/10899,0.0452975391230378,0.12296162767353594,0.07953130008053688,LRP1,1
R-HSA-109704,PI3K Cascade,1/12,44/10899,0.04740689259702591,0.12296162767353594,0.07953130008053688,IRS2,1
R-HSA-975634,Retinoid metabolism and transport,1/12,44/10899,0.04740689259702591,0.12296162767353594,0.07953130008053688,LRP1,1
R-HSA-112399,IRS-mediated signalling,1/12,48/10899,0.05161278873359443,0.12320120698988854,0.07968625943543836,IRS2,1
R-HSA-6806667,Metabolism of fat-soluble vitamins,1/12,48/10899,0.05161278873359443,0.12320120698988854,0.07968625943543836,LRP1,1
R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,1/12,50/10899,0.05370934712339526,0.12320120698988854,0.07968625943543836,CHSY1,1
R-HSA-2428928,IRS-related events triggered by IGF1R,1/12,52/10899,0.05580165619062616,0.12320120698988854,0.07968625943543836,IRS2,1
R-HSA-2428924,IGF1R signaling cascade,1/12,53/10899,0.05684621967598713,0.12320120698988854,0.07968625943543836,IRS2,1
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1/12,54/10899,0.05788972376633317,0.12320120698988854,0.07968625943543836,IRS2,1
R-HSA-74751,Insulin receptor signalling cascade,1/12,54/10899,0.05788972376633317,0.12320120698988854,0.07968625943543836,IRS2,1
R-HSA-71291,Metabolism of amino acids and derivatives,2/12,374/10899,0.06176184114970643,0.12815582038564086,0.08289089206934283,SLC3A2/GLUL,2
R-HSA-174824,"Plasma lipoprotein assembly, remodeling, and clearance",1/12,74/10899,0.07853883105582682,0.1577676558542615,0.10204375965209052,PCSK5,1
R-HSA-3000178,ECM proteoglycans,1/12,76/10899,0.08058075537206955,0.1577676558542615,0.10204375965209052,ITGA7,1
R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,1/12,78/10899,0.08261853116150941,0.1577676558542615,0.10204375965209052,IRS2,1
R-HSA-74752,Signaling by Insulin receptor,1/12,79/10899,0.08363586575406634,0.1577676558542615,0.10204375965209052,IRS2,1
R-HSA-69202,Cyclin E associated events during G1/S transition ,1/12,83/10899,0.08769487109169294,0.15843850098539794,0.10247766075149392,WEE1,1
R-HSA-216083,Integrin cell surface interactions,1/12,85/10899,0.08971818730498438,0.15843850098539794,0.10247766075149392,ITGA7,1
R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,1/12,85/10899,0.08971818730498438,0.15843850098539794,0.10247766075149392,WEE1,1
R-HSA-449147,Signaling by Interleukins,2/12,473/10899,0.09306287785632038,0.16092122629322067,0.10408348181298992,IRS2/CLCF1,2
R-HSA-69473,G2/M DNA damage checkpoint,1/12,94/10899,0.09877230747872501,0.16730819430069746,0.10821455813995651,WEE1,1
R-HSA-2219528,PI3K/AKT Signaling in Cancer,1/12,104/10899,0.10873557010731627,0.17671987367036435,0.11430201087112976,IRS2,1
R-HSA-2187338,Visual phototransduction,1/12,105/10899,0.10972632260001791,0.17671987367036435,0.11430201087112976,LRP1,1
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/12,106/10899,0.1107160654320355,0.17671987367036435,0.11430201087112976,IRS2,1
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/12,113/10899,0.11761607323888756,0.1772323756024781,0.11463349595087359,IRS2,1
R-HSA-187037,Signaling by NTRK1 (TRKA),1/12,115/10899,0.11957847028600932,0.1772323756024781,0.11463349595087359,IRS2,1
R-HSA-927802,Nonsense-Mediated Decay (NMD),1/12,115/10899,0.11957847028600932,0.1772323756024781,0.11463349595087359,SMG6,1
R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),1/12,115/10899,0.11957847028600932,0.1772323756024781,0.11463349595087359,SMG6,1
R-HSA-1630316,Glycosaminoglycan metabolism,1/12,124/10899,0.12835984710476578,0.1869099528016765,0.12089293079119216,CHSY1,1
R-HSA-114608,Platelet degranulation ,1/12,129/10899,0.13320362597947044,0.18693566980557294,0.1209095644906052,ACTN4,1
R-HSA-1500931,Cell-Cell communication,1/12,129/10899,0.13320362597947044,0.18693566980557294,0.1209095644906052,ACTN4,1
R-HSA-69206,G1/S Transition,1/12,131/10899,0.13513421913655876,0.18693566980557294,0.1209095644906052,WEE1,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,1/12,134/10899,0.13802271923131904,0.1878014048557292,0.1214695199447329,ACTN4,1
R-HSA-202733,Cell surface interactions at the vascular wall,1/12,137/10899,0.14090237370322567,0.1886273712478666,0.12200375312163854,SLC3A2,1
R-HSA-3781865,Diseases of glycosylation,1/12,143/10899,0.14663524424768282,0.1931861154374234,0.12495233845667209,CHSY1,1
R-HSA-453279,Mitotic G1 phase and G1/S transition,1/12,149/10899,0.15233302709163365,0.1975568945094624,0.12777934838278482,WEE1,1
R-HSA-69242,S Phase,1/12,163/10899,0.1654924969951057,0.21077879499372937,0.13633124343284966,WEE1,1
R-HSA-69481,G2/M Checkpoints,1/12,167/10899,0.1692177979089543,0.21077879499372937,0.13633124343284966,WEE1,1
R-HSA-983231,Factors involved in megakaryocyte development and platelet production,1/12,168/10899,0.17014673812746828,0.21077879499372937,0.13633124343284966,WEE1,1
R-HSA-196854,Metabolism of vitamins and cofactors,1/12,190/10899,0.1903440747227434,0.23233173826452505,0.15027163793900794,LRP1,1
R-HSA-69275,G2/M Transition,1/12,196/10899,0.195773685395227,0.23426883404136437,0.15152454706543542,WEE1,1
R-HSA-453274,Mitotic G2-G2/M phases,1/12,198/10899,0.19757612509512656,0.23426883404136437,0.15152454706543542,WEE1,1
R-HSA-5668914,Diseases of metabolism,1/12,249/10899,0.2423058566049332,0.28325895912971066,0.18321124813716222,CHSY1,1
R-HSA-76002,"Platelet activation, signaling and aggregation",1/12,263/10899,0.25417826462492665,0.29167803543524873,0.18865668747238662,ACTN4,1
R-HSA-1257604,PIP3 activates AKT signaling,1/12,267/10899,0.25753892050650773,0.29167803543524873,0.18865668747238662,IRS2,1
R-HSA-112315,Transmission across Chemical Synapses,1/12,270/10899,0.2600502966531133,0.29167803543524873,0.18865668747238662,GLUL,1
R-HSA-5673001,RAF/MAP kinase cascade,1/12,280/10899,0.2683654196166536,0.29699106437576334,0.1920931424624468,IRS2,1
R-HSA-5684996,MAPK1/MAPK3 signaling,1/12,286/10899,0.2733132893667275,0.2984868818083998,0.19306063376320087,IRS2,1
R-HSA-69620,Cell Cycle Checkpoints,1/12,293/10899,0.27904702733448195,0.2986697582588197,0.1931789178338593,WEE1,1
R-HSA-71387,Metabolism of carbohydrates,1/12,295/10899,0.2806776041468426,0.2986697582588197,0.1931789178338593,CHSY1,1
R-HSA-1474244,Extracellular matrix organization,1/12,300/10899,0.2847392674370358,0.2991564455351136,0.19349370605314892,ITGA7,1
R-HSA-9006925,Intracellular signaling by second messengers,1/12,309/10899,0.2919973249087118,0.3029472245927885,0.19594557329400394,IRS2,1
R-HSA-5683057,MAPK family signaling cascades,1/12,325/10899,0.30473406458780095,0.3122583624788578,0.20196799602310395,IRS2,1
R-HSA-112316,Neuronal System,1/12,410/10899,0.3689462954386169,0.3734456405049415,0.2415437877711099,GLUL,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,1/12,433/10899,0.3853610890200512,0.3853610890200512,0.24925067266991263,IRS2,1
HALLMARK_TNFA_SIGNALING_VIA_NFKB,HALLMARK_TNFA_SIGNALING_VIA_NFKB,2/9,200/4383,0.060367138606587004,0.34343645249916344,0.34343645249916344,IRS2/CLCF1,2
HALLMARK_PROTEIN_SECRETION,HALLMARK_PROTEIN_SECRETION,1/9,96/4383,0.18086000329858487,0.34343645249916344,0.34343645249916344,SCRN1,1
HALLMARK_COAGULATION,HALLMARK_COAGULATION,1/9,138/4383,0.2503821828119722,0.34343645249916344,0.34343645249916344,LRP1,1
HALLMARK_FATTY_ACID_METABOLISM,HALLMARK_FATTY_ACID_METABOLISM,1/9,158/4383,0.28160448746536493,0.34343645249916344,0.34343645249916344,GLUL,1
HALLMARK_APOPTOSIS,HALLMARK_APOPTOSIS,1/9,161/4383,0.2861867272291707,0.34343645249916344,0.34343645249916344,WEE1,1
HALLMARK_MITOTIC_SPINDLE,HALLMARK_MITOTIC_SPINDLE,1/9,199/4383,0.34202110592970025,0.34343645249916344,0.34343645249916344,ACTN4,1
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.34343645249916344,ITGA7,1
HALLMARK_APICAL_JUNCTION,HALLMARK_APICAL_JUNCTION,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.34343645249916344,ACTN4,1
HALLMARK_COMPLEMENT,HALLMARK_COMPLEMENT,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.34343645249916344,LRP1,1
HALLMARK_E2F_TARGETS,HALLMARK_E2F_TARGETS,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.34343645249916344,WEE1,1
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.34343645249916344,LRP1,1
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.34343645249916344,IRS2,1
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.34343645249916344,IRS2,1
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.34343645249916344,ITGA7,1
HALLMARK_P53_PATHWAY,HALLMARK_P53_PATHWAY,1/9,200/4383,0.34343645249916344,0.34343645249916344,0.34343645249916344,SLC3A2,1
VERHAAK_GLIOBLASTOMA_CLASSICAL,VERHAAK_GLIOBLASTOMA_CLASSICAL,4/19,161/21728,1.0320626078476144e-5,0.006295581907870448,0.0040630675298421876,ITGA7/PCSK5/IRS2/MCC,4
AMIT_EGF_RESPONSE_120_HELA,AMIT_EGF_RESPONSE_120_HELA,3/19,68/21728,2.7406609302861764e-5,0.008359015837372839,0.0053947746733001584,ZFP36L2/IRS2/CLCF1,3
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,4/19,262/21728,6.944003348869231e-5,0.014119473476034105,0.009112481587638922,SCRN1/IRS2/LRP1/WDR41,4
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,4/19,289/21728,1.0149119631410005e-4,0.015477407437900258,0.009988870374071954,ZFP36L2/WEE1/CHSY1/SLC20A2,4
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,3/19,138/21728,2.2546041605553884e-4,0.02750617075877574,0.017752041179951904,ZFP36L2/LRP1/GLUL,3
BURTON_ADIPOGENESIS_1,BURTON_ADIPOGENESIS_1,2/19,31/21728,3.3181097465902665e-4,0.02966144109720564,0.01914301806791184,WEE1/IRS2,2
AMIT_SERUM_RESPONSE_40_MCF10A,AMIT_SERUM_RESPONSE_40_MCF10A,2/19,33/21728,3.7637339228917125e-4,0.02966144109720564,0.01914301806791184,WEE1/GLUL,2
WANG_METHYLATED_IN_BREAST_CANCER,WANG_METHYLATED_IN_BREAST_CANCER,2/19,35/21728,4.236909449063334e-4,0.02966144109720564,0.01914301806791184,SLC3A2/IRS2,2
NAGASHIMA_NRG1_SIGNALING_UP,NAGASHIMA_NRG1_SIGNALING_UP,3/19,173/21728,4.376278194669685e-4,0.02966144109720564,0.01914301806791184,WEE1/IRS2/CLCF1,3
NAKAMURA_METASTASIS,NAKAMURA_METASTASIS,2/19,47/21728,7.649655206057654e-4,0.046662896756951684,0.030115484705953294,SCRN1/GLUL,2
GENTILE_UV_RESPONSE_CLUSTER_D4,GENTILE_UV_RESPONSE_CLUSTER_D4,2/19,54/21728,0.0010089552643639359,0.055951155569272805,0.03610997788249876,CHSY1/SLC20A2,2
WP_PROXIMAL_TUBULE_TRANSPORT,WP_PROXIMAL_TUBULE_TRANSPORT,2/19,58/21728,0.0011630548793716967,0.05912195636806125,0.03815636183201883,SLC3A2/SLC20A2,2
AMIT_SERUM_RESPONSE_120_MCF10A,AMIT_SERUM_RESPONSE_120_MCF10A,2/19,65/21728,0.0014581672825308683,0.06842169556490997,0.04415826426449755,IRS2/CLCF1,2
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,2/19,74/21728,0.0018846616507391582,0.08078673505302766,0.05213846231204892,ITGA7/ACTN4,2
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,2/19,76/21728,0.001986559058681008,0.08078673505302766,0.05213846231204892,ITGA7/ACTN4,2
SMID_BREAST_CANCER_LUMINAL_A_UP,SMID_BREAST_CANCER_LUMINAL_A_UP,2/19,85/21728,0.0024767966160095817,0.0944278709853653,0.06094223252549892,ITGA7/PCSK5,2
JIANG_VHL_TARGETS,JIANG_VHL_TARGETS,2/19,88/21728,0.0026516489353473464,0.09514740297422832,0.06140660692383329,SLC3A2/LRP1,2
REACTOME_SLC_TRANSPORTER_DISORDERS,REACTOME_SLC_TRANSPORTER_DISORDERS,2/19,99/21728,0.0033411025631651546,0.10665138724528538,0.06883109375278126,SLC3A2/SLC20A2,2
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,2/19,102/21728,0.0035421940967182773,0.10665138724528538,0.06883109375278126,IRS2/GLUL,2
WANG_LMO4_TARGETS_DN,WANG_LMO4_TARGETS_DN,3/19,361/21728,0.0036169438281873096,0.10665138724528538,0.06883109375278126,SLC3A2/CLCF1/WDR41,3
REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,2/19,106/21728,0.003818936515201931,0.10665138724528538,0.06883109375278126,SLC3A2/SLC20A2,2
WANG_LMO4_TARGETS_UP,WANG_LMO4_TARGETS_UP,3/19,369/21728,0.0038464434744201284,0.10665138724528538,0.06883109375278126,ZFP36L2/WEE1/GLUL,3
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,3/19,395/21728,0.004653397780379405,0.12146915425954458,0.07839424278355422,ZFP36L2/ACTN4/SLC20A2,3
TSENG_IRS1_TARGETS_UP,TSENG_IRS1_TARGETS_UP,2/19,119/21728,0.004785645940196196,0.12146915425954458,0.07839424278355422,SLC3A2/ACTN4,2
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,2/19,129/21728,0.005598270875460672,0.12146915425954458,0.07839424278355422,LRP1/ACTN4,2
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,3/19,428/21728,0.00581638289219873,0.12146915425954458,0.07839424278355422,LRP1/CLCF1/SLC20A2,3
REACTOME_SIGNALING_BY_NTRKS,REACTOME_SIGNALING_BY_NTRKS,2/19,134/21728,0.006026737293822803,0.12146915425954458,0.07839424278355422,PCSK5/IRS2,2
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,2/19,151/21728,0.007592046066123485,0.12146915425954458,0.07839424278355422,WEE1/ACTN4,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,2/19,151/21728,0.007592046066123485,0.12146915425954458,0.07839424278355422,PCSK5/GLUL,2
MATZUK_PREOVULATORY_FOLLICLE,MATZUK_PREOVULATORY_FOLLICLE,1/19,10/21728,0.008711944995094978,0.12146915425954458,0.07839424278355422,IRS2,1
MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,1/19,10/21728,0.008711944995094978,0.12146915425954458,0.07839424278355422,MCC,1
REACTOME_SIGNAL_ATTENUATION,REACTOME_SIGNAL_ATTENUATION,1/19,10/21728,0.008711944995094978,0.12146915425954458,0.07839424278355422,IRS2,1
BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP,1/19,11/21728,0.009579173701471544,0.12146915425954458,0.07839424278355422,GLUL,1
REACTOME_SIGNALING_BY_LEPTIN,REACTOME_SIGNALING_BY_LEPTIN,1/19,11/21728,0.009579173701471544,0.12146915425954458,0.07839424278355422,IRS2,1
TAGHAVI_NEOPLASTIC_TRANSFORMATION,TAGHAVI_NEOPLASTIC_TRANSFORMATION,1/19,11/21728,0.009579173701471544,0.12146915425954458,0.07839424278355422,ACTN4,1
WHITESIDE_CISPLATIN_RESISTANCE_UP,WHITESIDE_CISPLATIN_RESISTANCE_UP,1/19,11/21728,0.009579173701471544,0.12146915425954458,0.07839424278355422,ITGA7,1
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,2/19,177/21728,0.010301848449842712,0.12146915425954458,0.07839424278355422,SLC3A2/SLC20A2,2
KIM_GERMINAL_CENTER_T_HELPER_DN,KIM_GERMINAL_CENTER_T_HELPER_DN,1/19,12/21728,0.010445683610744383,0.12146915425954458,0.07839424278355422,IRS2,1
NEBEN_AML_WITH_FLT3_OR_NRAS_DN,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,1/19,12/21728,0.010445683610744383,0.12146915425954458,0.07839424278355422,WEE1,1
REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,1/19,12/21728,0.010445683610744383,0.12146915425954458,0.07839424278355422,IRS2,1
BIOCARTA_RB_PATHWAY,BIOCARTA_RB_PATHWAY,1/19,13/21728,0.011311475285610717,0.12146915425954458,0.07839424278355422,WEE1,1
REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,1/19,13/21728,0.011311475285610717,0.12146915425954458,0.07839424278355422,WEE1,1
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,2/19,190/21728,0.011795485978675926,0.12146915425954458,0.07839424278355422,WEE1/MCC,2
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,1/19,14/21728,0.012176549288353766,0.12146915425954458,0.07839424278355422,ZFP36L2,1
REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,1/19,14/21728,0.012176549288353766,0.12146915425954458,0.07839424278355422,IRS2,1
REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM,REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM,1/19,14/21728,0.012176549288353766,0.12146915425954458,0.07839424278355422,GLUL,1
REACTOME_TRYPTOPHAN_CATABOLISM,REACTOME_TRYPTOPHAN_CATABOLISM,1/19,14/21728,0.012176549288353766,0.12146915425954458,0.07839424278355422,SLC3A2,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,1/19,14/21728,0.012176549288353766,0.12146915425954458,0.07839424278355422,LRP1,1
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,2/19,199/21728,0.012882253174279625,0.12146915425954458,0.07839424278355422,ITGA7/ACTN4,2
JIANG_HYPOXIA_NORMAL,JIANG_HYPOXIA_NORMAL,2/19,200/21728,0.013005632136085916,0.12146915425954458,0.07839424278355422,SLC3A2/LRP1,2
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,1/19,15/21728,0.013040906180843859,0.12146915425954458,0.07839424278355422,LRP1,1
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,2/19,202/21728,0.01325395538351172,0.12146915425954458,0.07839424278355422,WDR41/MCC,2
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,2/19,202/21728,0.01325395538351172,0.12146915425954458,0.07839424278355422,ITGA7/ACTN4,2
KYNG_DNA_DAMAGE_UP,KYNG_DNA_DAMAGE_UP,2/19,205/21728,0.013630339989186805,0.12146915425954458,0.07839424278355422,PCSK5/LRP1,2
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,2/19,207/21728,0.013883852348571016,0.12146915425954458,0.07839424278355422,PCSK5/GLUL,2
GHO_ATF5_TARGETS_DN,GHO_ATF5_TARGETS_DN,1/19,16/21728,0.013904546524534767,0.12146915425954458,0.07839424278355422,ACTN4,1
REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS,REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS,1/19,16/21728,0.013904546524534767,0.12146915425954458,0.07839424278355422,WEE1,1
RIZKI_TUMOR_INVASIVENESS_3D_UP,RIZKI_TUMOR_INVASIVENESS_3D_UP,2/19,209/21728,0.014139427733605782,0.12146915425954458,0.07839424278355422,SLC3A2/IRS2,2
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,2/19,213/21728,0.014656738852806446,0.12146915425954458,0.07839424278355422,ITGA7/ACTN4,2
GENTILE_UV_RESPONSE_CLUSTER_D1,GENTILE_UV_RESPONSE_CLUSTER_D1,1/19,17/21728,0.014767470880468703,0.12146915425954458,0.07839424278355422,WEE1,1
HAHTOLA_MYCOSIS_FUNGOIDES_DN,HAHTOLA_MYCOSIS_FUNGOIDES_DN,1/19,17/21728,0.014767470880468703,0.12146915425954458,0.07839424278355422,ZFP36L2,1
REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,1/19,17/21728,0.014767470880468703,0.12146915425954458,0.07839424278355422,CLCF1,1
WP_LEPTININSULIN_SIGNALING_OVERLAP,WP_LEPTININSULIN_SIGNALING_OVERLAP,1/19,17/21728,0.014767470880468703,0.12146915425954458,0.07839424278355422,IRS2,1
AMIT_DELAYED_EARLY_GENES,AMIT_DELAYED_EARLY_GENES,1/19,18/21728,0.015629679809273433,0.12146915425954458,0.07839424278355422,ZFP36L2,1
KANG_AR_TARGETS_DN,KANG_AR_TARGETS_DN,1/19,18/21728,0.015629679809273433,0.12146915425954458,0.07839424278355422,SLC20A2,1
MOREIRA_RESPONSE_TO_TSA_DN,MOREIRA_RESPONSE_TO_TSA_DN,1/19,18/21728,0.015629679809273433,0.12146915425954458,0.07839424278355422,SLC3A2,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,1/19,18/21728,0.015629679809273433,0.12146915425954458,0.07839424278355422,LRP1,1
WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,1/19,18/21728,0.015629679809273433,0.12146915425954458,0.07839424278355422,LRP1,1
JEON_SMAD6_TARGETS_DN,JEON_SMAD6_TARGETS_DN,1/19,19/21728,0.016491173871162057,0.12146915425954458,0.07839424278355422,IRS2,1
JIANG_HYPOXIA_VIA_VHL,JIANG_HYPOXIA_VIA_VHL,1/19,19/21728,0.016491173871162057,0.12146915425954458,0.07839424278355422,SLC3A2,1
REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,1/19,19/21728,0.016491173871162057,0.12146915425954458,0.07839424278355422,PCSK5,1
SCIBETTA_KDM5B_TARGETS_UP,SCIBETTA_KDM5B_TARGETS_UP,1/19,19/21728,0.016491173871162057,0.12146915425954458,0.07839424278355422,CLCF1,1
WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,1/19,19/21728,0.016491173871162057,0.12146915425954458,0.07839424278355422,PCSK5,1
WP_FARNESOID_X_RECEPTOR_PATHWAY,WP_FARNESOID_X_RECEPTOR_PATHWAY,1/19,19/21728,0.016491173871162057,0.12146915425954458,0.07839424278355422,IRS2,1
WP_PROTEOGLYCAN_BIOSYNTHESIS,WP_PROTEOGLYCAN_BIOSYNTHESIS,1/19,19/21728,0.016491173871162057,0.12146915425954458,0.07839424278355422,CHSY1,1
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,2/19,227/21728,0.016531262086945952,0.12146915425954458,0.07839424278355422,ZFP36L2/ACTN4,2
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,2/19,230/21728,0.01694572654010953,0.12146915425954458,0.07839424278355422,ZFP36L2/WEE1,2
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,2/19,232/21728,0.01722451435796486,0.12146915425954458,0.07839424278355422,WEE1/SLC20A2,2
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,1/19,20/21728,0.01735195362593933,0.12146915425954458,0.07839424278355422,ZFP36L2,1
MARCHINI_TRABECTEDIN_RESISTANCE_UP,MARCHINI_TRABECTEDIN_RESISTANCE_UP,1/19,20/21728,0.01735195362593933,0.12146915425954458,0.07839424278355422,GLUL,1
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,1/19,20/21728,0.01735195362593933,0.12146915425954458,0.07839424278355422,CLCF1,1
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,1/19,20/21728,0.01735195362593933,0.12146915425954458,0.07839424278355422,CHSY1,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,2/19,238/21728,0.01807269617624365,0.12146915425954458,0.07839424278355422,SLC3A2/ITGA7,2
VERRECCHIA_RESPONSE_TO_TGFB1_C2,VERRECCHIA_RESPONSE_TO_TGFB1_C2,1/19,21/21728,0.01821201963299246,0.12146915425954458,0.07839424278355422,LRP1,1
WP_FOXA2_PATHWAY,WP_FOXA2_PATHWAY,1/19,21/21728,0.01821201963299246,0.12146915425954458,0.07839424278355422,IRS2,1
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,2/19,243/21728,0.018792952564961378,0.12146915425954458,0.07839424278355422,SLC3A2/LRP1,2
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,1/19,22/21728,0.01907137245129864,0.12146915425954458,0.07839424278355422,CHSY1,1
NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,1/19,22/21728,0.01907137245129864,0.12146915425954458,0.07839424278355422,CHSY1,1
WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,1/19,22/21728,0.01907137245129864,0.12146915425954458,0.07839424278355422,LRP1,1
WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,1/19,22/21728,0.01907137245129864,0.12146915425954458,0.07839424278355422,IRS2,1
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,2/19,249/21728,0.019673224290449685,0.12146915425954458,0.07839424278355422,SLC3A2/SLC20A2,2
KEGG_NITROGEN_METABOLISM,KEGG_NITROGEN_METABOLISM,1/19,23/21728,0.019930012639422512,0.12146915425954458,0.07839424278355422,GLUL,1
REACTOME_NEPHRIN_FAMILY_INTERACTIONS,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,1/19,23/21728,0.019930012639422512,0.12146915425954458,0.07839424278355422,ACTN4,1
BARIS_THYROID_CANCER_UP,BARIS_THYROID_CANCER_UP,1/19,24/21728,0.020787940755518264,0.12146915425954458,0.07839424278355422,GLUL,1
BIOCARTA_G2_PATHWAY,BIOCARTA_G2_PATHWAY,1/19,24/21728,0.020787940755518264,0.12146915425954458,0.07839424278355422,WEE1,1
HANSON_HRAS_SIGNALING_VIA_NFKB,HANSON_HRAS_SIGNALING_VIA_NFKB,1/19,24/21728,0.020787940755518264,0.12146915425954458,0.07839424278355422,CLCF1,1
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,1/19,24/21728,0.020787940755518264,0.12146915425954458,0.07839424278355422,IRS2,1
REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,1/19,24/21728,0.020787940755518264,0.12146915425954458,0.07839424278355422,CLCF1,1
VALK_AML_WITH_11Q23_REARRANGED,VALK_AML_WITH_11Q23_REARRANGED,1/19,24/21728,0.020787940755518264,0.12146915425954458,0.07839424278355422,ITGA7,1
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,2/19,258/21728,0.021025899225659034,0.12146915425954458,0.07839424278355422,PCSK5/IRS2,2
OLSSON_E2F3_TARGETS_UP,OLSSON_E2F3_TARGETS_UP,1/19,25/21728,0.021645157357326084,0.12146915425954458,0.07839424278355422,SMG6,1
REACTOME_BASIGIN_INTERACTIONS,REACTOME_BASIGIN_INTERACTIONS,1/19,25/21728,0.021645157357326084,0.12146915425954458,0.07839424278355422,SLC3A2,1
REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,1/19,25/21728,0.021645157357326084,0.12146915425954458,0.07839424278355422,WEE1,1
REACTOME_SIGNALING_BY_ERYTHROPOIETIN,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,1/19,25/21728,0.021645157357326084,0.12146915425954458,0.07839424278355422,IRS2,1
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,1/19,25/21728,0.021645157357326084,0.12146915425954458,0.07839424278355422,GLUL,1
WP_ALZHEIMERS_DISEASE,WP_ALZHEIMERS_DISEASE,2/19,266/21728,0.022260339269165784,0.12146915425954458,0.07839424278355422,IRS2/LRP1,2
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,1/19,26/21728,0.02250166300217793,0.12146915425954458,0.07839424278355422,GLUL,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,1/19,26/21728,0.02250166300217793,0.12146915425954458,0.07839424278355422,SCRN1,1
HAHTOLA_CTCL_CUTANEOUS,HAHTOLA_CTCL_CUTANEOUS,1/19,26/21728,0.02250166300217793,0.12146915425954458,0.07839424278355422,GLUL,1
NEWMAN_ERCC6_TARGETS_UP,NEWMAN_ERCC6_TARGETS_UP,1/19,26/21728,0.02250166300217793,0.12146915425954458,0.07839424278355422,PCSK5,1
PID_INTEGRIN_CS_PATHWAY,PID_INTEGRIN_CS_PATHWAY,1/19,26/21728,0.02250166300217793,0.12146915425954458,0.07839424278355422,ITGA7,1
TERAMOTO_OPN_TARGETS_CLUSTER_6,TERAMOTO_OPN_TARGETS_CLUSTER_6,1/19,26/21728,0.02250166300217793,0.12146915425954458,0.07839424278355422,ACTN4,1
WP_EPO_RECEPTOR_SIGNALING,WP_EPO_RECEPTOR_SIGNALING,1/19,26/21728,0.02250166300217793,0.12146915425954458,0.07839424278355422,IRS2,1
SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,1/19,27/21728,0.023357458246992313,0.12370645096678577,0.07983815817355976,IRS2,1
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,1/19,27/21728,0.023357458246992313,0.12370645096678577,0.07983815817355976,GLUL,1
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,2/19,274/21728,0.023524505429749425,0.12370645096678577,0.07983815817355976,SCRN1/YTHDF1,2
ABE_VEGFA_TARGETS_30MIN,ABE_VEGFA_TARGETS_30MIN,1/19,29/21728,0.0250669197621346,0.12478780273578324,0.08053604525139418,SCRN1,1
PID_IGF1_PATHWAY,PID_IGF1_PATHWAY,1/19,29/21728,0.0250669197621346,0.12478780273578324,0.08053604525139418,IRS2,1
VALK_AML_CLUSTER_16,VALK_AML_CLUSTER_16,1/19,29/21728,0.0250669197621346,0.12478780273578324,0.08053604525139418,ITGA7,1
BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,1/19,30/21728,0.025920587144249385,0.12478780273578324,0.08053604525139418,ACTN4,1
REACTOME_LAMININ_INTERACTIONS,REACTOME_LAMININ_INTERACTIONS,1/19,30/21728,0.025920587144249385,0.12478780273578324,0.08053604525139418,ITGA7,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,1/19,30/21728,0.025920587144249385,0.12478780273578324,0.08053604525139418,GLUL,1
TERAO_AOX4_TARGETS_SKIN_UP,TERAO_AOX4_TARGETS_SKIN_UP,1/19,30/21728,0.025920587144249385,0.12478780273578324,0.08053604525139418,SMG6,1
BENPORATH_OCT4_TARGETS,BENPORATH_OCT4_TARGETS,2/19,290/21728,0.026140307893532905,0.12478780273578324,0.08053604525139418,WEE1/MCC,2
BILANGES_SERUM_SENSITIVE_VIA_TSC2,BILANGES_SERUM_SENSITIVE_VIA_TSC2,1/19,31/21728,0.0267735463499027,0.12478780273578324,0.08053604525139418,SMG6,1
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,1/19,31/21728,0.0267735463499027,0.12478780273578324,0.08053604525139418,IRS2,1
DASU_IL6_SIGNALING_SCAR_UP,DASU_IL6_SIGNALING_SCAR_UP,1/19,31/21728,0.0267735463499027,0.12478780273578324,0.08053604525139418,ZFP36L2,1
CAFFAREL_RESPONSE_TO_THC_UP,CAFFAREL_RESPONSE_TO_THC_UP,1/19,32/21728,0.027625797933962803,0.12478780273578324,0.08053604525139418,SLC3A2,1
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,1/19,32/21728,0.027625797933962803,0.12478780273578324,0.08053604525139418,GLUL,1
CHO_NR4A1_TARGETS,CHO_NR4A1_TARGETS,1/19,32/21728,0.027625797933962803,0.12478780273578324,0.08053604525139418,SLC3A2,1
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,1/19,32/21728,0.027625797933962803,0.12478780273578324,0.08053604525139418,GLUL,1
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,1/19,32/21728,0.027625797933962803,0.12478780273578324,0.08053604525139418,ZFP36L2,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,2/19,300/21728,0.027833195091162895,0.12478780273578324,0.08053604525139418,SLC3A2/WEE1,2
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,2/19,303/21728,0.028349609211785427,0.12478780273578324,0.08053604525139418,YTHDF1/OPA3,2
PID_EPO_PATHWAY,PID_EPO_PATHWAY,1/19,33/21728,0.028477342450889953,0.12478780273578324,0.08053604525139418,IRS2,1
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,1/19,33/21728,0.028477342450889953,0.12478780273578324,0.08053604525139418,SLC3A2,1
ROZANOV_MMP14_TARGETS_SUBSET,ROZANOV_MMP14_TARGETS_SUBSET,1/19,33/21728,0.028477342450889953,0.12478780273578324,0.08053604525139418,CHSY1,1
WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,1/19,33/21728,0.028477342450889953,0.12478780273578324,0.08053604525139418,LRP1,1
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,1/19,34/21728,0.02932818045473584,0.12478780273578324,0.08053604525139418,GLUL,1
REACTOME_PLASMA_LIPOPROTEIN_REMODELING,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1/19,34/21728,0.02932818045473584,0.12478780273578324,0.08053604525139418,PCSK5,1
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,2/19,309/21728,0.029394135141591043,0.12478780273578324,0.08053604525139418,ITGA7/IRS2,2
FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,2/19,311/21728,0.029745752914849953,0.12478780273578324,0.08053604525139418,LRP1/MCC,2
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,2/19,313/21728,0.03009908127031852,0.12478780273578324,0.08053604525139418,SLC20A2/MCC,2
GENTILE_UV_RESPONSE_CLUSTER_D5,GENTILE_UV_RESPONSE_CLUSTER_D5,1/19,35/21728,0.03017831249914238,0.12478780273578324,0.08053604525139418,ZFP36L2,1
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,1/19,35/21728,0.03017831249914238,0.12478780273578324,0.08053604525139418,ZFP36L2,1
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,1/19,35/21728,0.03017831249914238,0.12478780273578324,0.08053604525139418,ACTN4,1
WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,WP_ALPHA_6_BETA_4_SIGNALING_PATHWAY,1/19,35/21728,0.03017831249914238,0.12478780273578324,0.08053604525139418,IRS2,1
DOUGLAS_BMI1_TARGETS_DN,DOUGLAS_BMI1_TARGETS_DN,2/19,314/21728,0.030276384926058882,0.12478780273578324,0.08053604525139418,WEE1/SLC20A2,2
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,1/19,36/21728,0.031027739137344468,0.12510064984462832,0.08073795175477308,SLC3A2,1
REACTOME_INTERLEUKIN_7_SIGNALING,REACTOME_INTERLEUKIN_7_SIGNALING,1/19,36/21728,0.031027739137344468,0.12510064984462832,0.08073795175477308,IRS2,1
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,1/19,36/21728,0.031027739137344468,0.12510064984462832,0.08073795175477308,ITGA7,1
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,1/19,37/21728,0.031876460922168115,0.12510064984462832,0.08073795175477308,SLC3A2,1
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,1/19,38/21728,0.03272447840603143,0.12510064984462832,0.08073795175477308,ITGA7,1
WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,1/19,38/21728,0.03272447840603143,0.12510064984462832,0.08073795175477308,ACTN4,1
AMIT_SERUM_RESPONSE_480_MCF10A,AMIT_SERUM_RESPONSE_480_MCF10A,1/19,39/21728,0.03357179214094541,0.12510064984462832,0.08073795175477308,ACTN4,1
LEE_CALORIE_RESTRICTION_MUSCLE_UP,LEE_CALORIE_RESTRICTION_MUSCLE_UP,1/19,39/21728,0.03357179214094541,0.12510064984462832,0.08073795175477308,GLUL,1
PID_RET_PATHWAY,PID_RET_PATHWAY,1/19,39/21728,0.03357179214094541,0.12510064984462832,0.08073795175477308,IRS2,1
WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,2/19,336/21728,0.034283258737933614,0.12510064984462832,0.08073795175477308,IRS2/LRP1,2
REACTOME_RET_SIGNALING,REACTOME_RET_SIGNALING,1/19,40/21728,0.03441840267851415,0.12510064984462832,0.08073795175477308,IRS2,1
TOMLINS_PROSTATE_CANCER_DN,TOMLINS_PROSTATE_CANCER_DN,1/19,40/21728,0.03441840267851415,0.12510064984462832,0.08073795175477308,SCRN1,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,2/19,341/21728,0.035221750885560885,0.12510064984462832,0.08073795175477308,ZFP36L2/IRS2,2
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,1/19,41/21728,0.0352643105699334,0.12510064984462832,0.08073795175477308,MCC,1
MARTIN_INTERACT_WITH_HDAC,MARTIN_INTERACT_WITH_HDAC,1/19,41/21728,0.0352643105699334,0.12510064984462832,0.08073795175477308,ACTN4,1
PID_AMB2_NEUTROPHILS_PATHWAY,PID_AMB2_NEUTROPHILS_PATHWAY,1/19,41/21728,0.0352643105699334,0.12510064984462832,0.08073795175477308,LRP1,1
PIONTEK_PKD1_TARGETS_UP,PIONTEK_PKD1_TARGETS_UP,1/19,41/21728,0.0352643105699334,0.12510064984462832,0.08073795175477308,GLUL,1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,1/19,41/21728,0.0352643105699334,0.12510064984462832,0.08073795175477308,CHSY1,1
YAGI_AML_WITH_11Q23_REARRANGED,YAGI_AML_WITH_11Q23_REARRANGED,2/19,345/21728,0.03597982409207785,0.12510064984462832,0.08073795175477308,ITGA7/GLUL,2
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,1/19,42/21728,0.03610951636599424,0.12510064984462832,0.08073795175477308,IRS2,1
PID_UPA_UPAR_PATHWAY,PID_UPA_UPAR_PATHWAY,1/19,42/21728,0.03610951636599424,0.12510064984462832,0.08073795175477308,LRP1,1
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,1/19,43/21728,0.03695402061708031,0.12510064984462832,0.08073795175477308,LRP1,1
LEIN_ASTROCYTE_MARKERS,LEIN_ASTROCYTE_MARKERS,1/19,43/21728,0.03695402061708031,0.12510064984462832,0.08073795175477308,GLUL,1
ABE_INNER_EAR,ABE_INNER_EAR,1/19,44/21728,0.0377978238731681,0.12510064984462832,0.08073795175477308,LRP1,1
LIU_TARGETS_OF_VMYB_VS_CMYB_DN,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,1/19,44/21728,0.0377978238731681,0.12510064984462832,0.08073795175477308,CHSY1,1
VARELA_ZMPSTE24_TARGETS_UP,VARELA_ZMPSTE24_TARGETS_UP,1/19,44/21728,0.0377978238731681,0.12510064984462832,0.08073795175477308,ZFP36L2,1
BURTON_ADIPOGENESIS_4,BURTON_ADIPOGENESIS_4,1/19,45/21728,0.03864092668383112,0.12510064984462832,0.08073795175477308,GLUL,1
FAELT_B_CLL_WITH_VH3_21_UP,FAELT_B_CLL_WITH_VH3_21_UP,1/19,45/21728,0.03864092668383112,0.12510064984462832,0.08073795175477308,ACTN4,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,1/19,45/21728,0.03864092668383112,0.12510064984462832,0.08073795175477308,ZFP36L2,1
PID_NFAT_TFPATHWAY,PID_NFAT_TFPATHWAY,1/19,45/21728,0.03864092668383112,0.12510064984462832,0.08073795175477308,SLC3A2,1
WP_NEPHROTIC_SYNDROME,WP_NEPHROTIC_SYNDROME,1/19,45/21728,0.03864092668383112,0.12510064984462832,0.08073795175477308,ACTN4,1
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,2/19,361/21728,0.039075803741568306,0.12510064984462832,0.08073795175477308,PCSK5/LRP1,2
JIANG_TIP30_TARGETS_UP,JIANG_TIP30_TARGETS_UP,1/19,46/21728,0.03948332959823453,0.12510064984462832,0.08073795175477308,WEE1,1
LUI_THYROID_CANCER_PAX8_PPARG_UP,LUI_THYROID_CANCER_PAX8_PPARG_UP,1/19,46/21728,0.03948332959823453,0.12510064984462832,0.08073795175477308,SLC20A2,1
MARCHINI_TRABECTEDIN_RESISTANCE_DN,MARCHINI_TRABECTEDIN_RESISTANCE_DN,1/19,46/21728,0.03948332959823453,0.12510064984462832,0.08073795175477308,SLC3A2,1
PID_PLK1_PATHWAY,PID_PLK1_PATHWAY,1/19,46/21728,0.03948332959823453,0.12510064984462832,0.08073795175477308,WEE1,1
DELACROIX_RARG_BOUND_MEF,DELACROIX_RARG_BOUND_MEF,2/19,367/21728,0.04026263345866417,0.12510064984462832,0.08073795175477308,LRP1/CLCF1,2
HUANG_FOXA2_TARGETS_UP,HUANG_FOXA2_TARGETS_UP,1/19,47/21728,0.040325033165139135,0.12510064984462832,0.08073795175477308,GLUL,1
KEGG_TYPE_II_DIABETES_MELLITUS,KEGG_TYPE_II_DIABETES_MELLITUS,1/19,47/21728,0.040325033165139135,0.12510064984462832,0.08073795175477308,IRS2,1
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,1/19,47/21728,0.040325033165139135,0.12510064984462832,0.08073795175477308,CLBA1,1
YAMASHITA_LIVER_CANCER_STEM_CELL_UP,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,1/19,47/21728,0.040325033165139135,0.12510064984462832,0.08073795175477308,WEE1,1
ZHAN_MULTIPLE_MYELOMA_CD2_DN,ZHAN_MULTIPLE_MYELOMA_CD2_DN,1/19,47/21728,0.040325033165139135,0.12510064984462832,0.08073795175477308,MCC,1
BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,1/19,48/21728,0.0411660379329023,0.12510064984462832,0.08073795175477308,WEE1,1
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,1/19,48/21728,0.0411660379329023,0.12510064984462832,0.08073795175477308,SCRN1,1
GERHOLD_ADIPOGENESIS_UP,GERHOLD_ADIPOGENESIS_UP,1/19,48/21728,0.0411660379329023,0.12510064984462832,0.08073795175477308,ITGA7,1
PARK_APL_PATHOGENESIS_DN,PARK_APL_PATHOGENESIS_DN,1/19,48/21728,0.0411660379329023,0.12510064984462832,0.08073795175477308,GLUL,1
REACTOME_IRS_MEDIATED_SIGNALLING,REACTOME_IRS_MEDIATED_SIGNALLING,1/19,48/21728,0.0411660379329023,0.12510064984462832,0.08073795175477308,IRS2,1
REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,1/19,48/21728,0.0411660379329023,0.12510064984462832,0.08073795175477308,LRP1,1
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,2/19,374/21728,0.04166475018327312,0.12510064984462832,0.08073795175477308,SLC3A2/GLUL,2
FAELT_B_CLL_WITH_VH3_21_DN,FAELT_B_CLL_WITH_VH3_21_DN,1/19,49/21728,0.04200634444947404,0.12510064984462832,0.08073795175477308,SCRN1,1
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,1/19,49/21728,0.04200634444947404,0.12510064984462832,0.08073795175477308,WEE1,1
PID_ARF6_TRAFFICKING_PATHWAY,PID_ARF6_TRAFFICKING_PATHWAY,1/19,49/21728,0.04200634444947404,0.12510064984462832,0.08073795175477308,ITGA7,1
PRAMOONJAGO_SOX4_TARGETS_DN,PRAMOONJAGO_SOX4_TARGETS_DN,1/19,49/21728,0.04200634444947404,0.12510064984462832,0.08073795175477308,GLUL,1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,1/19,50/21728,0.04284595326240148,0.12510064984462832,0.08073795175477308,SLC3A2,1
CHIBA_RESPONSE_TO_TSA_UP,CHIBA_RESPONSE_TO_TSA_UP,1/19,50/21728,0.04284595326240148,0.12510064984462832,0.08073795175477308,ITGA7,1
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,1/19,50/21728,0.04284595326240148,0.12510064984462832,0.08073795175477308,CHSY1,1
TSUNODA_CISPLATIN_RESISTANCE_DN,TSUNODA_CISPLATIN_RESISTANCE_DN,1/19,50/21728,0.04284595326240148,0.12510064984462832,0.08073795175477308,SLC3A2,1
ZHAN_MULTIPLE_MYELOMA_MS_UP,ZHAN_MULTIPLE_MYELOMA_MS_UP,1/19,50/21728,0.04284595326240148,0.12510064984462832,0.08073795175477308,PCSK5,1
ZHU_CMV_8_HR_DN,ZHU_CMV_8_HR_DN,1/19,50/21728,0.04284595326240148,0.12510064984462832,0.08073795175477308,WEE1,1
DAIRKEE_CANCER_PRONE_RESPONSE_BPA,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,1/19,51/21728,0.04368486491882806,0.12510064984462832,0.08073795175477308,GLUL,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1/19,51/21728,0.04368486491882806,0.12510064984462832,0.08073795175477308,SLC3A2,1
SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,1/19,51/21728,0.04368486491882806,0.12510064984462832,0.08073795175477308,IRS2,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,2/19,390/21728,0.04493896810301235,0.12510064984462832,0.08073795175477308,ITGA7/ZFP36L2,2
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,1/19,53/21728,0.04536059894872979,0.12510064984462832,0.08073795175477308,GLUL,1
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SMIRNOV_RESPONSE_TO_IR_2HR_UP,1/19,53/21728,0.04536059894872979,0.12510064984462832,0.08073795175477308,ZFP36L2,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,ZFP36L2,1
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,ACTN4,1
IKEDA_MIR1_TARGETS_UP,IKEDA_MIR1_TARGETS_UP,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,ZFP36L2,1
KEGG_ARGININE_AND_PROLINE_METABOLISM,KEGG_ARGININE_AND_PROLINE_METABOLISM,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,GLUL,1
LEE_LIVER_CANCER_MYC_UP,LEE_LIVER_CANCER_MYC_UP,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,GLUL,1
MARSON_FOXP3_TARGETS_DN,MARSON_FOXP3_TARGETS_DN,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,ZFP36L2,1
REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,IRS2,1
REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,IRS2,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,WEE1,1
SUNG_METASTASIS_STROMA_DN,SUNG_METASTASIS_STROMA_DN,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,SCRN1,1
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,LRP1,1
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,1/19,54/21728,0.046197422414472555,0.12510064984462832,0.08073795175477308,CLCF1,1
PID_IL2_1PATHWAY,PID_IL2_1PATHWAY,1/19,55/21728,0.04703355090824968,0.12510064984462832,0.08073795175477308,IRS2,1
WP_IL4_SIGNALING_PATHWAY,WP_IL4_SIGNALING_PATHWAY,1/19,55/21728,0.04703355090824968,0.12510064984462832,0.08073795175477308,IRS2,1
WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,WP_INTERFERON_TYPE_I_SIGNALING_PATHWAYS,1/19,55/21728,0.04703355090824968,0.12510064984462832,0.08073795175477308,IRS2,1
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,1/19,56/21728,0.047868984975187545,0.12510064984462832,0.08073795175477308,SLC3A2,1
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,2/19,407/21728,0.048520859513503475,0.12510064984462832,0.08073795175477308,LRP1/ACTN4,2
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,1/19,57/21728,0.04870372516000965,0.12510064984462832,0.08073795175477308,SLC20A2,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,2/19,408/21728,0.04873479135472293,0.12510064984462832,0.08073795175477308,CLBA1/MCC,2
AMIT_SERUM_RESPONSE_60_MCF10A,AMIT_SERUM_RESPONSE_60_MCF10A,1/19,58/21728,0.04953777200703868,0.12510064984462832,0.08073795175477308,IRS2,1
KANNAN_TP53_TARGETS_UP,KANNAN_TP53_TARGETS_UP,1/19,58/21728,0.04953777200703868,0.12510064984462832,0.08073795175477308,SLC3A2,1
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,1/19,58/21728,0.04953777200703868,0.12510064984462832,0.08073795175477308,SCRN1,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,1/19,58/21728,0.04953777200703868,0.12510064984462832,0.08073795175477308,PCSK5,1
BOYLAN_MULTIPLE_MYELOMA_C_DN,BOYLAN_MULTIPLE_MYELOMA_C_DN,1/19,59/21728,0.05037112606019356,0.12510064984462832,0.08073795175477308,IRS2,1
CORRE_MULTIPLE_MYELOMA_DN,CORRE_MULTIPLE_MYELOMA_DN,1/19,59/21728,0.05037112606019356,0.12510064984462832,0.08073795175477308,ZFP36L2,1
CHANG_IMMORTALIZED_BY_HPV31_DN,CHANG_IMMORTALIZED_BY_HPV31_DN,1/19,60/21728,0.05120378786299273,0.12510064984462832,0.08073795175477308,LRP1,1
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,1/19,60/21728,0.05120378786299273,0.12510064984462832,0.08073795175477308,IRS2,1
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,1/19,60/21728,0.05120378786299273,0.12510064984462832,0.08073795175477308,LRP1,1
NADLER_OBESITY_UP,NADLER_OBESITY_UP,1/19,60/21728,0.05120378786299273,0.12510064984462832,0.08073795175477308,LRP1,1
WP_PREIMPLANTATION_EMBRYO,WP_PREIMPLANTATION_EMBRYO,1/19,60/21728,0.05120378786299273,0.12510064984462832,0.08073795175477308,ZFP36L2,1
ZHENG_GLIOBLASTOMA_PLASTICITY_DN,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,1/19,60/21728,0.05120378786299273,0.12510064984462832,0.08073795175477308,ITGA7,1
CUI_GLUCOSE_DEPRIVATION,CUI_GLUCOSE_DEPRIVATION,1/19,61/21728,0.05203575795855331,0.12510064984462832,0.08073795175477308,SLC3A2,1
DASU_IL6_SIGNALING_UP,DASU_IL6_SIGNALING_UP,1/19,61/21728,0.05203575795855331,0.12510064984462832,0.08073795175477308,ZFP36L2,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,1/19,61/21728,0.05203575795855331,0.12510064984462832,0.08073795175477308,SLC3A2,1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,1/19,61/21728,0.05203575795855331,0.12510064984462832,0.08073795175477308,ZFP36L2,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,1/19,62/21728,0.0528670368895906,0.12510064984462832,0.08073795175477308,ZFP36L2,1
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/19,62/21728,0.0528670368895906,0.12510064984462832,0.08073795175477308,ACTN4,1
NAKAMURA_ADIPOGENESIS_EARLY_UP,NAKAMURA_ADIPOGENESIS_EARLY_UP,1/19,62/21728,0.0528670368895906,0.12510064984462832,0.08073795175477308,IRS2,1
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,1/19,63/21728,0.05369762519841981,0.12510064984462832,0.08073795175477308,WEE1,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,1/19,63/21728,0.05369762519841981,0.12510064984462832,0.08073795175477308,GLUL,1
PHONG_TNF_TARGETS_UP,PHONG_TNF_TARGETS_UP,1/19,63/21728,0.05369762519841981,0.12510064984462832,0.08073795175477308,ZFP36L2,1
RIZKI_TUMOR_INVASIVENESS_2D_DN,RIZKI_TUMOR_INVASIVENESS_2D_DN,1/19,63/21728,0.05369762519841981,0.12510064984462832,0.08073795175477308,SLC20A2,1
VILLANUEVA_LIVER_CANCER_KRT19_DN,VILLANUEVA_LIVER_CANCER_KRT19_DN,1/19,63/21728,0.05369762519841981,0.12510064984462832,0.08073795175477308,LRP1,1
WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,1/19,63/21728,0.05369762519841981,0.12510064984462832,0.08073795175477308,ZFP36L2,1
ZHANG_BREAST_CANCER_PROGENITORS_UP,ZHANG_BREAST_CANCER_PROGENITORS_UP,2/19,432/21728,0.05397392273512426,0.12510064984462832,0.08073795175477308,WEE1/SLC20A2,2
GENTILE_UV_LOW_DOSE_DN,GENTILE_UV_LOW_DOSE_DN,1/19,64/21728,0.05452752342695577,0.12510064984462832,0.08073795175477308,SLC20A2,1
PID_IL4_2PATHWAY,PID_IL4_2PATHWAY,1/19,64/21728,0.05452752342695577,0.12510064984462832,0.08073795175477308,IRS2,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,WP_G1_TO_S_CELL_CYCLE_CONTROL,1/19,64/21728,0.05452752342695577,0.12510064984462832,0.08073795175477308,WEE1,1
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,2/19,437/21728,0.055090220396162334,0.12510064984462832,0.08073795175477308,SCRN1/GLUL,2
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,2/19,438/21728,0.05531448585514667,0.12510064984462832,0.08073795175477308,CHSY1/MCC,2
WP_FERROPTOSIS,WP_FERROPTOSIS,1/19,65/21728,0.05535673211671277,0.12510064984462832,0.08073795175477308,SLC3A2,1
GRYDER_PAX3FOXO1_TOP_ENHANCERS,GRYDER_PAX3FOXO1_TOP_ENHANCERS,2/19,441/21728,0.05598928174468526,0.12510064984462832,0.08073795175477308,CHSY1/MCC,2
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,1/19,66/21728,0.056185251808804404,0.12510064984462832,0.08073795175477308,ZFP36L2,1
PID_INTEGRIN1_PATHWAY,PID_INTEGRIN1_PATHWAY,1/19,66/21728,0.056185251808804404,0.12510064984462832,0.08073795175477308,ITGA7,1
SWEET_KRAS_TARGETS_DN,SWEET_KRAS_TARGETS_DN,1/19,66/21728,0.056185251808804404,0.12510064984462832,0.08073795175477308,IRS2,1
URS_ADIPOCYTE_DIFFERENTIATION_UP,URS_ADIPOCYTE_DIFFERENTIATION_UP,1/19,66/21728,0.056185251808804404,0.12510064984462832,0.08073795175477308,GLUL,1
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,1/19,66/21728,0.056185251808804404,0.12510064984462832,0.08073795175477308,YTHDF1,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,2/19,445/21728,0.05689364963124466,0.12510064984462832,0.08073795175477308,SLC3A2/IRS2,2
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,2/19,445/21728,0.05689364963124466,0.12510064984462832,0.08073795175477308,ITGA7/MCC,2
CADWELL_ATG16L1_TARGETS_DN,CADWELL_ATG16L1_TARGETS_DN,1/19,67/21728,0.05701308304394537,0.12510064984462832,0.08073795175477308,MCC,1
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,1/19,67/21728,0.05701308304394537,0.12510064984462832,0.08073795175477308,IRS2,1
PID_TELOMERASE_PATHWAY,PID_TELOMERASE_PATHWAY,1/19,67/21728,0.05701308304394537,0.12510064984462832,0.08073795175477308,SMG6,1
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,1/19,67/21728,0.05701308304394537,0.12510064984462832,0.08073795175477308,LRP1,1
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,1/19,67/21728,0.05701308304394537,0.12510064984462832,0.08073795175477308,SLC3A2,1
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1/19,67/21728,0.05701308304394537,0.12510064984462832,0.08073795175477308,IRS2,1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,1/19,69/21728,0.058666682304239104,0.1273547195928322,0.08219269219623686,WEE1,1
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,1/19,69/21728,0.058666682304239104,0.1273547195928322,0.08219269219623686,SLC3A2,1
REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,1/19,69/21728,0.058666682304239104,0.1273547195928322,0.08219269219623686,LRP1,1
CROONQUIST_NRAS_SIGNALING_DN,CROONQUIST_NRAS_SIGNALING_DN,1/19,70/21728,0.05949245140882453,0.1275478008143012,0.08231730371794418,WEE1,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,1/19,70/21728,0.05949245140882453,0.1275478008143012,0.08231730371794418,IRS2,1
DER_IFN_GAMMA_RESPONSE_UP,DER_IFN_GAMMA_RESPONSE_UP,1/19,71/21728,0.06031753421532693,0.1275478008143012,0.08231730371794418,ZFP36L2,1
LIN_APC_TARGETS,LIN_APC_TARGETS,1/19,71/21728,0.06031753421532693,0.1275478008143012,0.08231730371794418,ACTN4,1
REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,1/19,71/21728,0.06031753421532693,0.1275478008143012,0.08231730371794418,PCSK5,1
SESTO_RESPONSE_TO_UV_C8,SESTO_RESPONSE_TO_UV_C8,1/19,71/21728,0.06031753421532693,0.1275478008143012,0.08231730371794418,SCRN1,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,2/19,461/21728,0.060563318491054625,0.1275478008143012,0.08231730371794418,ITGA7/GLUL,2
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,2/19,463/21728,0.0610278104805786,0.1275478008143012,0.08231730371794418,IRS2/CLCF1,2
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,2/19,463/21728,0.0610278104805786,0.1275478008143012,0.08231730371794418,LRP1/SMG6,2
DELACROIX_RAR_BOUND_ES,DELACROIX_RAR_BOUND_ES,2/19,467/21728,0.061960591303544484,0.1275478008143012,0.08231730371794418,WEE1/ACTN4,2
HOSHIDA_LIVER_CANCER_SURVIVAL_UP,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1/19,73/21728,0.06196564308856645,0.1275478008143012,0.08231730371794418,CHSY1,1
KEGG_ADHERENS_JUNCTION,KEGG_ADHERENS_JUNCTION,1/19,73/21728,0.06196564308856645,0.1275478008143012,0.08231730371794418,ACTN4,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,2/19,470/21728,0.06266347829108876,0.1275478008143012,0.08231730371794418,ZFP36L2/CLBA1,2
DER_IFN_ALPHA_RESPONSE_UP,DER_IFN_ALPHA_RESPONSE_UP,1/19,74/21728,0.06278867023155077,0.1275478008143012,0.08231730371794418,ZFP36L2,1
SESTO_RESPONSE_TO_UV_C1,SESTO_RESPONSE_TO_UV_C1,1/19,74/21728,0.06278867023155077,0.1275478008143012,0.08231730371794418,GLUL,1
WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,1/19,74/21728,0.06278867023155077,0.1275478008143012,0.08231730371794418,ACTN4,1
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,2/19,473/21728,0.063369175222801,0.1275478008143012,0.08231730371794418,SLC3A2/SLC20A2,2
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,2/19,474/21728,0.06360502889544745,0.1275478008143012,0.08231730371794418,SLC3A2/ZFP36L2,2
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1/19,75/21728,0.06361101322894624,0.1275478008143012,0.08231730371794418,GLUL,1
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,1/19,75/21728,0.06361101322894624,0.1275478008143012,0.08231730371794418,ZFP36L2,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,2/19,476/21728,0.06407766434759048,0.1275478008143012,0.08231730371794418,SLC3A2/GLUL,2
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,1/19,76/21728,0.06443267261788277,0.1275478008143012,0.08231730371794418,ACTN4,1
REACTOME_ECM_PROTEOGLYCANS,REACTOME_ECM_PROTEOGLYCANS,1/19,76/21728,0.06443267261788277,0.1275478008143012,0.08231730371794418,ITGA7,1
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,1/19,76/21728,0.06443267261788277,0.1275478008143012,0.08231730371794418,GLUL,1
WP_PROLACTIN_SIGNALING_PATHWAY,WP_PROLACTIN_SIGNALING_PATHWAY,1/19,76/21728,0.06443267261788277,0.1275478008143012,0.08231730371794418,IRS2,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,1/19,76/21728,0.06443267261788277,0.1275478008143012,0.08231730371794418,ZFP36L2,1
CARD_MIR302A_TARGETS,CARD_MIR302A_TARGETS,1/19,77/21728,0.06525364893509433,0.1275478008143012,0.08231730371794418,WEE1,1
CROMER_METASTASIS_DN,CROMER_METASTASIS_DN,1/19,77/21728,0.06525364893509433,0.1275478008143012,0.08231730371794418,SLC20A2,1
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,1/19,77/21728,0.06525364893509433,0.1275478008143012,0.08231730371794418,LRP1,1
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,1/19,77/21728,0.06525364893509433,0.1275478008143012,0.08231730371794418,ACTN4,1
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1/19,77/21728,0.06525364893509433,0.1275478008143012,0.08231730371794418,PCSK5,1
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,2/19,484/21728,0.06598048510484222,0.1275478008143012,0.08231730371794418,ITGA7/PCSK5,2
REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,1/19,78/21728,0.06607394271691669,0.1275478008143012,0.08231730371794418,IRS2,1
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,1/19,78/21728,0.06607394271691669,0.1275478008143012,0.08231730371794418,IRS2,1
WOO_LIVER_CANCER_RECURRENCE_DN,WOO_LIVER_CANCER_RECURRENCE_DN,1/19,78/21728,0.06607394271691669,0.1275478008143012,0.08231730371794418,GLUL,1
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,1/19,79/21728,0.06689355449928946,0.12872261275888508,0.08307550849322351,WEE1,1
BURTON_ADIPOGENESIS_8,BURTON_ADIPOGENESIS_8,1/19,80/21728,0.06771248481775793,0.1290239131683826,0.08326996294214857,ZFP36L2,1
FALVELLA_SMOKERS_WITH_LUNG_CANCER,FALVELLA_SMOKERS_WITH_LUNG_CANCER,1/19,81/21728,0.0685307342074688,0.1290239131683826,0.08326996294214857,ZFP36L2,1
MORI_PRE_BI_LYMPHOCYTE_UP,MORI_PRE_BI_LYMPHOCYTE_UP,1/19,81/21728,0.0685307342074688,0.1290239131683826,0.08326996294214857,ACTN4,1
ROSS_AML_WITH_MLL_FUSIONS,ROSS_AML_WITH_MLL_FUSIONS,1/19,81/21728,0.0685307342074688,0.1290239131683826,0.08326996294214857,ITGA7,1
ROSS_LEUKEMIA_WITH_MLL_FUSIONS,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,1/19,81/21728,0.0685307342074688,0.1290239131683826,0.08326996294214857,ITGA7,1
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,1/19,81/21728,0.0685307342074688,0.1290239131683826,0.08326996294214857,SLC3A2,1
ZAMORA_NOS2_TARGETS_DN,ZAMORA_NOS2_TARGETS_DN,1/19,81/21728,0.0685307342074688,0.1290239131683826,0.08326996294214857,ACTN4,1
RADMACHER_AML_PROGNOSIS,RADMACHER_AML_PROGNOSIS,1/19,82/21728,0.0693483032031752,0.13016143062749808,0.08400409845502033,GLUL,1
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,1/19,83/21728,0.0701651923392348,0.13120804639776212,0.08467956747672656,ITGA7,1
BROWNE_HCMV_INFECTION_16HR_DN,BROWNE_HCMV_INFECTION_16HR_DN,1/19,84/21728,0.07098140214960902,0.13120804639776212,0.08467956747672656,ZFP36L2,1
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,1/19,84/21728,0.07098140214960902,0.13120804639776212,0.08467956747672656,ITGA7,1
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1/19,84/21728,0.07098140214960902,0.13120804639776212,0.08467956747672656,MCC,1
ZHU_CMV_24_HR_DN,ZHU_CMV_24_HR_DN,1/19,84/21728,0.07098140214960902,0.13120804639776212,0.08467956747672656,WEE1,1
REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,1/19,85/21728,0.07179693316786606,0.13191605190481415,0.08513650286868076,WEE1,1
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,1/19,85/21728,0.07179693316786606,0.13191605190481415,0.08513650286868076,ITGA7,1
COATES_MACROPHAGE_M1_VS_M2_UP,COATES_MACROPHAGE_M1_VS_M2_UP,1/19,86/21728,0.07261178592717898,0.13261433956760235,0.08558716651990211,CLBA1,1
LEIN_CEREBELLUM_MARKERS,LEIN_CEREBELLUM_MARKERS,1/19,86/21728,0.07261178592717898,0.13261433956760235,0.08558716651990211,MCC,1
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,1/19,88/21728,0.07423945879969429,0.13465261995922595,0.0869026399736851,PCSK5,1
WP_RETINOBLASTOMA_GENE_IN_CANCER,WP_RETINOBLASTOMA_GENE_IN_CANCER,1/19,88/21728,0.07423945879969429,0.13465261995922595,0.0869026399736851,WEE1,1
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,1/19,89/21728,0.07505227997727348,0.13465261995922595,0.0869026399736851,GLUL,1
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,1/19,89/21728,0.07505227997727348,0.13465261995922595,0.0869026399736851,GLUL,1
SAFFORD_T_LYMPHOCYTE_ANERGY,SAFFORD_T_LYMPHOCYTE_ANERGY,1/19,89/21728,0.07505227997727348,0.13465261995922595,0.0869026399736851,ACTN4,1
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,1/19,89/21728,0.07505227997727348,0.13465261995922595,0.0869026399736851,MCC,1
BOYLAN_MULTIPLE_MYELOMA_D_UP,BOYLAN_MULTIPLE_MYELOMA_D_UP,1/19,90/21728,0.07586442502466129,0.13531374054106254,0.0873293165873294,CLBA1,1
KEGG_DILATED_CARDIOMYOPATHY,KEGG_DILATED_CARDIOMYOPATHY,1/19,90/21728,0.07586442502466129,0.13531374054106254,0.0873293165873294,ITGA7,1
MORI_IMMATURE_B_LYMPHOCYTE_DN,MORI_IMMATURE_B_LYMPHOCYTE_DN,1/19,91/21728,0.07667589447306411,0.13596597566444507,0.08775025866868415,ACTN4,1
WP_AMINO_ACID_METABOLISM,WP_AMINO_ACID_METABOLISM,1/19,91/21728,0.07667589447306411,0.13596597566444507,0.08775025866868415,GLUL,1
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1/19,92/21728,0.0774866888532928,0.1370054498565467,0.08842111863045463,WEE1,1
KAYO_CALORIE_RESTRICTION_MUSCLE_UP,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,1/19,94/21728,0.07910625453051612,0.13906286819485542,0.08974894340789634,LRP1,1
WP_TNFALPHA_SIGNALING_PATHWAY,WP_TNFALPHA_SIGNALING_PATHWAY,1/19,94/21728,0.07910625453051612,0.13906286819485542,0.08974894340789634,GLUL,1
CROONQUIST_IL6_DEPRIVATION_DN,CROONQUIST_IL6_DEPRIVATION_DN,1/19,95/21728,0.07991502688717278,0.1392804754319297,0.08988938362647406,WEE1,1
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,1/19,95/21728,0.07991502688717278,0.1392804754319297,0.08988938362647406,IRS2,1
REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,1/19,95/21728,0.07991502688717278,0.1392804754319297,0.08988938362647406,WEE1,1
NAKAMURA_ADIPOGENESIS_LATE_UP,NAKAMURA_ADIPOGENESIS_LATE_UP,1/19,97/21728,0.08153055328279679,0.14169127493591466,0.09144527493707004,IRS2,1
IGARASHI_ATF4_TARGETS_DN,IGARASHI_ATF4_TARGETS_DN,1/19,98/21728,0.08233730837907605,0.14228260088168948,0.09182690721268658,SLC3A2,1
REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,1/19,98/21728,0.08233730837907605,0.14228260088168948,0.09182690721268658,LRP1,1
HAHTOLA_SEZARY_SYNDROM_UP,HAHTOLA_SEZARY_SYNDROM_UP,1/19,99/21728,0.08314339211189192,0.14326968697246914,0.09246395673460477,GLUL,1
PID_CXCR4_PATHWAY,PID_CXCR4_PATHWAY,1/19,100/21728,0.08394880500892221,0.14384486251528805,0.09283516579934036,ITGA7,1
REACTOME_VISUAL_PHOTOTRANSDUCTION,REACTOME_VISUAL_PHOTOTRANSDUCTION,1/19,100/21728,0.08394880500892221,0.14384486251528805,0.09283516579934036,LRP1,1
KANG_IMMORTALIZED_BY_TERT_DN,KANG_IMMORTALIZED_BY_TERT_DN,1/19,101/21728,0.08475354759745712,0.14441246936996885,0.09320149015421632,GLUL,1
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,1/19,101/21728,0.08475354759745712,0.14441246936996885,0.09320149015421632,SLC3A2,1
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,1/19,102/21728,0.0855576204043953,0.14497263457411425,0.0935630117872627,GLUL,1
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,1/19,102/21728,0.0855576204043953,0.14497263457411425,0.0935630117872627,SLC3A2,1
DER_IFN_BETA_RESPONSE_UP,DER_IFN_BETA_RESPONSE_UP,1/19,103/21728,0.0863610239562459,0.1459286000368698,0.09417997655528786,ZFP36L2,1
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,1/19,104/21728,0.08716375877912819,0.14687815705875193,0.09479280541841799,ITGA7,1
REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1/19,105/21728,0.08796582539877251,0.1478213594855406,0.09540153312785538,IRS2,1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,1/19,106/21728,0.08876722434052098,0.14794537390086832,0.09548157004128516,ZFP36L2,1
ROESSLER_LIVER_CANCER_METASTASIS_UP,ROESSLER_LIVER_CANCER_METASTASIS_UP,1/19,106/21728,0.08876722434052098,0.14794537390086832,0.09548157004128516,SLC20A2,1
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,1/19,106/21728,0.08876722434052098,0.14794537390086832,0.09548157004128516,ZFP36L2,1
HELLER_SILENCED_BY_METHYLATION_DN,HELLER_SILENCED_BY_METHYLATION_DN,1/19,107/21728,0.08956795612932522,0.1480662689400769,0.09555959375942844,SLC3A2,1
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,1/19,107/21728,0.08956795612932522,0.1480662689400769,0.09555959375942844,PCSK5,1
SERVITJA_ISLET_HNF1A_TARGETS_DN,SERVITJA_ISLET_HNF1A_TARGETS_DN,1/19,107/21728,0.08956795612932522,0.1480662689400769,0.09555959375942844,GLUL,1
LEE_EARLY_T_LYMPHOCYTE_UP,LEE_EARLY_T_LYMPHOCYTE_UP,1/19,110/21728,0.09196615382177586,0.1512111963107366,0.09758927941365918,SCRN1,1
WOOD_EBV_EBNA1_TARGETS_UP,WOOD_EBV_EBNA1_TARGETS_UP,1/19,110/21728,0.09196615382177586,0.1512111963107366,0.09758927941365918,GLUL,1
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,1/19,112/21728,0.09356162612535157,0.15342094606576467,0.0990154164427886,GLUL,1
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1/19,113/21728,0.09435836599876113,0.15431260927411336,0.09959088156776257,IRS2,1
DAZARD_RESPONSE_TO_UV_SCC_DN,DAZARD_RESPONSE_TO_UV_SCC_DN,1/19,115/21728,0.09594985580001791,0.15612224902227984,0.10075879401955594,WEE1,1
IKEDA_MIR30_TARGETS_UP,IKEDA_MIR30_TARGETS_UP,1/19,116/21728,0.09674460677118324,0.15612224902227984,0.10075879401955594,IRS2,1
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,1/19,116/21728,0.09674460677118324,0.15612224902227984,0.10075879401955594,ACTN4,1
LENAOUR_DENDRITIC_CELL_MATURATION_UP,LENAOUR_DENDRITIC_CELL_MATURATION_UP,1/19,116/21728,0.09674460677118324,0.15612224902227984,0.10075879401955594,SCRN1,1
REACTOME_NONSENSE_MEDIATED_DECAY_NMD,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,1/19,116/21728,0.09674460677118324,0.15612224902227984,0.10075879401955594,SMG6,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1/19,118/21728,0.09833212345998832,0.15826542298309465,0.10214196409952961,WEE1,1
ZHU_CMV_ALL_DN,ZHU_CMV_ALL_DN,1/19,119/21728,0.09912489021863058,0.15912153429832804,0.10269448460323502,WEE1,1
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,1/19,120/21728,0.09991699661345899,0.15997209431551176,0.10324342238826817,WDR41,1
CERVERA_SDHB_TARGETS_1_UP,CERVERA_SDHB_TARGETS_1_UP,1/19,121/21728,0.1007084431640114,0.16039725934738108,0.10351781707665321,PCSK5,1
IWANAGA_CARCINOGENESIS_BY_KRAS_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,1/19,121/21728,0.1007084431640114,0.16039725934738108,0.10351781707665321,IRS2,1
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,1/19,122/21728,0.10149923038944253,0.16081696243522065,0.10378868671401642,WEE1,1
WP_CELL_CYCLE,WP_CELL_CYCLE,1/19,122/21728,0.10149923038944253,0.16081696243522065,0.10378868671401642,WEE1,1
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,1/19,123/21728,0.10228935880852075,0.1612312890780301,0.10405608648004015,SLC3A2,1
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1/19,123/21728,0.10228935880852075,0.1612312890780301,0.10405608648004015,ITGA7,1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1/19,124/21728,0.10307882893963072,0.16205692178653283,0.10458893658009195,CHSY1,1
KEGG_CELL_CYCLE,KEGG_CELL_CYCLE,1/19,125/21728,0.10386764130077453,0.16245964408582683,0.10484884708904096,WEE1,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,1/19,125/21728,0.10386764130077453,0.16245964408582683,0.10484884708904096,SCRN1,1
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1/19,126/21728,0.10465579640956901,0.16327374887426369,0.10537425725448597,IRS2,1
SCHLOSSER_SERUM_RESPONSE_UP,SCHLOSSER_SERUM_RESPONSE_UP,1/19,127/21728,0.1054432947832481,0.16366516493074132,0.10562687089576749,ACTN4,1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,1/19,127/21728,0.1054432947832481,0.16366516493074132,0.10562687089576749,ACTN4,1
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,1/19,130/21728,0.10780185466018999,0.16473155989579238,0.10631510509236645,WEE1,1
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,1/19,130/21728,0.10780185466018999,0.16473155989579238,0.10631510509236645,ZFP36L2,1
REACTOME_CELL_CELL_COMMUNICATION,REACTOME_CELL_CELL_COMMUNICATION,1/19,130/21728,0.10780185466018999,0.16473155989579238,0.10631510509236645,ACTN4,1
SANSOM_APC_TARGETS_UP,SANSOM_APC_TARGETS_UP,1/19,131/21728,0.10858673125809049,0.16473155989579238,0.10631510509236645,GLUL,1
WP_ADIPOGENESIS,WP_ADIPOGENESIS,1/19,131/21728,0.10858673125809049,0.16473155989579238,0.10631510509236645,IRS2,1
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,1/19,131/21728,0.10858673125809049,0.16473155989579238,0.10631510509236645,ACTN4,1
KEGG_TIGHT_JUNCTION,KEGG_TIGHT_JUNCTION,1/19,132/21728,0.10937095370130478,0.16473155989579238,0.10631510509236645,ACTN4,1
POOLA_INVASIVE_BREAST_CANCER_DN,POOLA_INVASIVE_BREAST_CANCER_DN,1/19,132/21728,0.10937095370130478,0.16473155989579238,0.10631510509236645,ITGA7,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_5,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,1/19,132/21728,0.10937095370130478,0.16473155989579238,0.10631510509236645,PCSK5,1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1/19,132/21728,0.10937095370130478,0.16473155989579238,0.10631510509236645,ACTN4,1
WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1/19,132/21728,0.10937095370130478,0.16473155989579238,0.10631510509236645,IRS2,1
YAGI_AML_WITH_T_9_11_TRANSLOCATION,YAGI_AML_WITH_T_9_11_TRANSLOCATION,1/19,132/21728,0.10937095370130478,0.16473155989579238,0.10631510509236645,ITGA7,1
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,1/19,133/21728,0.11015452250477165,0.165503100315051,0.10681304489703033,ACTN4,1
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,1/19,135/21728,0.11171970125031505,0.16744230408523877,0.1080645758893517,WEE1,1
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,1/19,137/21728,0.11328227160660775,0.16895399921767906,0.10904019966766516,ITGA7,1
KEGG_INSULIN_SIGNALING_PATHWAY,KEGG_INSULIN_SIGNALING_PATHWAY,1/19,137/21728,0.11328227160660775,0.16895399921767906,0.10904019966766516,IRS2,1
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,1/19,138/21728,0.11406257992208557,0.1692899604683022,0.10925702366720454,IRS2,1
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1/19,138/21728,0.11406257992208557,0.1692899604683022,0.10925702366720454,ZFP36L2,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1/19,139/21728,0.11484223767944934,0.16962170698417459,0.10947112754457514,SLC3A2,1
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1/19,139/21728,0.11484223767944934,0.16962170698417459,0.10947112754457514,ACTN4,1
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,1/19,140/21728,0.11562124539097307,0.17035980601085404,0.10994748481114654,LRP1,1
PROVENZANI_METASTASIS_DN,PROVENZANI_METASTASIS_DN,1/19,142/21728,0.11717731272370091,0.1722365319553194,0.11115869361741065,SCRN1,1
REACTOME_DISEASES_OF_GLYCOSYLATION,REACTOME_DISEASES_OF_GLYCOSYLATION,1/19,143/21728,0.11795437336755532,0.17296194171684792,0.11162686143589498,CHSY1,1
WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING_PATHWAY,1/19,144/21728,0.11873078601087328,0.17326741499194426,0.11182400898531003,IRS2,1
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1/19,144/21728,0.11873078601087328,0.17326741499194426,0.11182400898531003,GLUL,1
BROCKE_APOPTOSIS_REVERSED_BY_IL6,BROCKE_APOPTOSIS_REVERSED_BY_IL6,1/19,146/21728,0.12028166933703388,0.17469480546569205,0.11274522388985132,ZFP36L2,1
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1/19,146/21728,0.12028166933703388,0.17469480546569205,0.11274522388985132,PCSK5,1
PODAR_RESPONSE_TO_ADAPHOSTIN_UP,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,1/19,148/21728,0.1218299667806717,0.1765232297772203,0.11392525959737772,SLC3A2,1
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1/19,149/21728,0.12260314706941888,0.17680359270058044,0.11410620132876113,YTHDF1,1
REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,1/19,149/21728,0.12260314706941888,0.17680359270058044,0.11410620132876113,WEE1,1
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,1/19,151/21728,0.12414757332321769,0.17860853709236507,0.11527108347289824,LRP1,1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1/19,152/21728,0.1249188203041165,0.17929524796590837,0.11571427565012897,ACTN4,1
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/19,155/21728,0.12722870274999265,0.18175528964284665,0.11730194706889499,GLUL,1
KEGG_JAK_STAT_SIGNALING_PATHWAY,KEGG_JAK_STAT_SIGNALING_PATHWAY,1/19,155/21728,0.12722870274999265,0.18175528964284665,0.11730194706889499,CLCF1,1
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,1/19,158/21728,0.12953280808543588,0.18461451619653244,0.11914724600086823,CLCF1,1
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,1/19,159/21728,0.13029956175471635,0.1850882177476511,0.11945296537984731,GLUL,1
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,1/19,160/21728,0.13106567554425985,0.1850882177476511,0.11945296537984731,ZFP36L2,1
WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1/19,160/21728,0.13106567554425985,0.1850882177476511,0.11945296537984731,IRS2,1
MULLIGHAN_NPM1_SIGNATURE_3_DN,MULLIGHAN_NPM1_SIGNATURE_3_DN,1/19,161/21728,0.13183114995842227,0.1850882177476511,0.11945296537984731,SCRN1,1
WP_INSULIN_SIGNALING,WP_INSULIN_SIGNALING,1/19,161/21728,0.13183114995842227,0.1850882177476511,0.11945296537984731,IRS2,1
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,1/19,162/21728,0.13259598550118612,0.1850882177476511,0.11945296537984731,SCRN1,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1/19,162/21728,0.13259598550118612,0.1850882177476511,0.11945296537984731,SLC3A2,1
REACTOME_S_PHASE,REACTOME_S_PHASE,1/19,162/21728,0.13259598550118612,0.1850882177476511,0.11945296537984731,WEE1,1
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,1/19,162/21728,0.13259598550118612,0.1850882177476511,0.11945296537984731,SLC3A2,1
AMIT_EGF_RESPONSE_480_HELA,AMIT_EGF_RESPONSE_480_HELA,1/19,164/21728,0.13412374198657728,0.18594427866320942,0.12000545335641127,ZFP36L2,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/19,164/21728,0.13412374198657728,0.18594427866320942,0.12000545335641127,WEE1,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,1/19,164/21728,0.13412374198657728,0.18594427866320942,0.12000545335641127,SCRN1,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,1/19,166/21728,0.13564894902481583,0.18720782557723453,0.120820926256921,GLUL,1
KEGG_ALZHEIMERS_DISEASE,KEGG_ALZHEIMERS_DISEASE,1/19,166/21728,0.13564894902481583,0.18720782557723453,0.120820926256921,LRP1,1
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,1/19,167/21728,0.13641059775723985,0.1876113957106095,0.12108138394437958,GLUL,1
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,1/19,168/21728,0.1371716106343145,0.1876113957106095,0.12108138394437958,WEE1,1
REACTOME_G2_M_CHECKPOINTS,REACTOME_G2_M_CHECKPOINTS,1/19,168/21728,0.1371716106343145,0.1876113957106095,0.12108138394437958,WEE1,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,1/19,168/21728,0.1371716106343145,0.1876113957106095,0.12108138394437958,CLCF1,1
SERVITJA_ISLET_HNF1A_TARGETS_UP,SERVITJA_ISLET_HNF1A_TARGETS_UP,1/19,169/21728,0.13793198815741048,0.18822933506939685,0.12148019208965388,ITGA7,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,1/19,170/21728,0.13869173082752562,0.18842306415320853,0.12160522173132009,MCC,1
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1/19,170/21728,0.13869173082752562,0.18842306415320853,0.12160522173132009,WEE1,1
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,1/19,173/21728,0.1409671547243898,0.1910888097375062,0.12332565115069426,IRS2,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1/19,175/21728,0.14248093889230573,0.19271257810267514,0.12437360519482402,GLUL,1
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,1/19,177/21728,0.14399219564068377,0.19432575075402014,0.12541472093529513,YTHDF1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1/19,178/21728,0.14474687747831683,0.19491301382289905,0.12579373109536537,ITGA7,1
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1/19,179/21728,0.14550092895525035,0.19549684286938923,0.12617052499249629,ZFP36L2,1
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,1/19,182/21728,0.14775930619291944,0.198094894016881,0.1278472655087377,ACTN4,1
WU_CELL_MIGRATION,WU_CELL_MIGRATION,1/19,183/21728,0.148510841196277,0.1986658182669495,0.12821573085735827,GLUL,1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,1/19,186/21728,0.15076168092017517,0.20123550407288152,0.12987416483737307,ZFP36L2,1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1/19,189/21728,0.15300688310762822,0.20378646003417733,0.13152051087624217,LRP1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,1/19,193/21728,0.1559917395711058,0.20649935424358284,0.13327136926160482,ZFP36L2,1
WIERENGA_STAT5A_TARGETS_DN,WIERENGA_STAT5A_TARGETS_DN,1/19,193/21728,0.1559917395711058,0.20649935424358284,0.13327136926160482,IRS2,1
ALONSO_METASTASIS_UP,ALONSO_METASTASIS_UP,1/19,194/21728,0.15673639510619486,0.20649935424358284,0.13327136926160482,WEE1,1
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,1/19,194/21728,0.15673639510619486,0.20649935424358284,0.13327136926160482,SLC3A2,1
YAGI_AML_FAB_MARKERS,YAGI_AML_FAB_MARKERS,1/19,194/21728,0.15673639510619486,0.20649935424358284,0.13327136926160482,SCRN1,1
KARLSSON_TGFB1_TARGETS_DN,KARLSSON_TGFB1_TARGETS_DN,1/19,195/21728,0.15748042819307995,0.2070324594779715,0.13361542682443717,GLUL,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,1/19,197/21728,0.15896662898752834,0.20853686813417696,0.1345863480279244,SCRN1,1
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,1/19,198/21728,0.15970879767682422,0.20876152270829404,0.13473133648473162,ZFP36L2,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1/19,199/21728,0.16045034588138274,0.20876152270829404,0.13473133648473162,WEE1,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,1/19,200/21728,0.1611912740911582,0.20876152270829404,0.13473133648473162,SLC20A2,1
LEE_DIFFERENTIATING_T_LYMPHOCYTE,LEE_DIFFERENTIATING_T_LYMPHOCYTE,1/19,200/21728,0.1611912740911582,0.20876152270829404,0.13473133648473162,ZFP36L2,1
MEBARKI_HCC_PROGENITOR_WNT_UP,MEBARKI_HCC_PROGENITOR_WNT_UP,1/19,200/21728,0.1611912740911582,0.20876152270829404,0.13473133648473162,PCSK5,1
REACTOME_MITOTIC_G2_G2_M_PHASES,REACTOME_MITOTIC_G2_G2_M_PHASES,1/19,200/21728,0.1611912740911582,0.20876152270829404,0.13473133648473162,WEE1,1
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,1/19,205/21728,0.16488663234123868,0.21264449413986383,0.13723734393150833,CHSY1,1
SHEPARD_CRASH_AND_BURN_MUTANT_UP,SHEPARD_CRASH_AND_BURN_MUTANT_UP,1/19,205/21728,0.16488663234123868,0.21264449413986383,0.13723734393150833,SLC3A2,1
LINSLEY_MIR16_TARGETS,LINSLEY_MIR16_TARGETS,1/19,206/21728,0.1656238508509963,0.21314461818377162,0.13756011596329695,WEE1,1
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1/19,207/21728,0.16636045278547418,0.21319301722508247,0.1375913519278358,SLC3A2,1
PEREZ_TP53_AND_TP63_TARGETS,PEREZ_TP53_AND_TP63_TARGETS,1/19,207/21728,0.16636045278547418,0.21319301722508247,0.1375913519278358,PCSK5,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,1/19,211/21728,0.16930070450613366,0.21650614203090468,0.1397295895074346,CHSY1,1
CAIRO_HEPATOBLASTOMA_UP,CAIRO_HEPATOBLASTOMA_UP,1/19,213/21728,0.17076714356086675,0.21792459743123163,0.140645037858983,GLUL,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,1/19,214/21728,0.17149944308549336,0.21840221353267422,0.1409532836259192,GLUL,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/19,215/21728,0.17223112992110634,0.21887706094140597,0.14125974252301268,SLC3A2,1
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,1/19,216/21728,0.17296220455186462,0.21934915753978673,0.1415644260912515,CLCF1,1
WP_CILIARY_LANDSCAPE,WP_CILIARY_LANDSCAPE,1/19,219/21728,0.17515176005120048,0.22166509052122882,0.1430590920706464,WEE1,1
BIDUS_METASTASIS_UP,BIDUS_METASTASIS_UP,1/19,220/21728,0.1758803906969313,0.2221263733439505,0.14335679660161774,YTHDF1,1
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,1/19,224/21728,0.1787888202035227,0.22533301719865464,0.1454263130842051,LRP1,1
RAO_BOUND_BY_SALL4,RAO_BOUND_BY_SALL4,1/19,229/21728,0.1824106837480005,0.2293866021955564,0.14804243178798634,WEE1,1
COLDREN_GEFITINIB_RESISTANCE_DN,COLDREN_GEFITINIB_RESISTANCE_DN,1/19,230/21728,0.18313323814628846,0.2293866021955564,0.14804243178798634,WEE1,1
MARKEY_RB1_ACUTE_LOF_DN,MARKEY_RB1_ACUTE_LOF_DN,1/19,230/21728,0.18313323814628846,0.2293866021955564,0.14804243178798634,PCSK5,1
DELYS_THYROID_CANCER_DN,DELYS_THYROID_CANCER_DN,1/19,233/21728,0.1852972733412569,0.23162159167657112,0.14948485813121243,ZFP36L2,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,1/19,235/21728,0.18673694491781423,0.2324148063191244,0.14999678613175588,PCSK5,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,1/19,235/21728,0.18673694491781423,0.2324148063191244,0.14999678613175588,CLCF1,1
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,1/19,236/21728,0.18745587657214624,0.2324148063191244,0.14999678613175588,PCSK5,1
FISCHER_G2_M_CELL_CYCLE,FISCHER_G2_M_CELL_CYCLE,1/19,236/21728,0.18745587657214624,0.2324148063191244,0.14999678613175588,WEE1,1
NABA_ECM_REGULATORS,NABA_ECM_REGULATORS,1/19,238/21728,0.18889193399616488,0.23365965058188296,0.15080018864128428,PCSK5,1
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,1/19,239/21728,0.18960906071808536,0.23365965058188296,0.15080018864128428,ITGA7,1
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,1/19,239/21728,0.18960906071808536,0.23365965058188296,0.15080018864128428,GLUL,1
DOANE_RESPONSE_TO_ANDROGEN_DN,DOANE_RESPONSE_TO_ANDROGEN_DN,1/19,243/21728,0.19247156543137667,0.23670898167971727,0.15276817799519288,ZFP36L2,1
BLUM_RESPONSE_TO_SALIRASIB_UP,BLUM_RESPONSE_TO_SALIRASIB_UP,1/19,245/21728,0.19389922312796204,0.23798496198804195,0.15359167520884848,LRP1,1
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,1/19,246/21728,0.19461215496991013,0.23838035046515094,0.15384685258665481,CHSY1,1
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,1/19,250/21728,0.19745791333057117,0.24041781862604472,0.1551618018397597,CLCF1,1
MITSIADES_RESPONSE_TO_APLIDIN_DN,MITSIADES_RESPONSE_TO_APLIDIN_DN,1/19,250/21728,0.19745791333057117,0.24041781862604472,0.1551618018397597,WEE1,1
VERHAAK_AML_WITH_NPM1_MUTATED_DN,VERHAAK_AML_WITH_NPM1_MUTATED_DN,1/19,250/21728,0.19745791333057117,0.24041781862604472,0.1551618018397597,SCRN1,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,1/19,251/21728,0.19816786303011102,0.24080158655053333,0.15540947949939513,MCC,1
BROWNE_HCMV_INFECTION_4HR_DN,BROWNE_HCMV_INFECTION_4HR_DN,1/19,254/21728,0.20029414393427591,0.24290144691830676,0.1567646956815302,MCC,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,1/19,256/21728,0.20170869574729966,0.244131556360819,0.15755858857454066,ZFP36L2,1
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,1/19,257/21728,0.20241508242673334,0.24450138669367788,0.1577972711362132,ITGA7,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1/19,261/21728,0.2052347119090142,0.24741734044367325,0.15967918089030855,ACTN4,1
LU_AGING_BRAIN_UP,LU_AGING_BRAIN_UP,1/19,263/21728,0.20664098286491583,0.24862130088283757,0.1604561976362058,CHSY1,1
DURCHDEWALD_SKIN_CARCINOGENESIS_DN,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1/19,265/21728,0.20804489628402545,0.24918794863266086,0.16082190300019875,IRS2,1
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,1/19,265/21728,0.20804489628402545,0.24918794863266086,0.16082190300019875,CLCF1,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,1/19,266/21728,0.20874597008408147,0.24918794863266086,0.16082190300019875,ACTN4,1
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,1/19,266/21728,0.20874597008408147,0.24918794863266086,0.16082190300019875,ITGA7,1
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,1/19,267/21728,0.2094464558994018,0.24953581659889668,0.16104641140291176,CHSY1,1
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,1/19,268/21728,0.21014635419574923,0.24988162974543282,0.161269593657967,GLUL,1
REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1/19,270/21728,0.21154439009284165,0.25105462637477316,0.16202662685792096,GLUL,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,1/19,272/21728,0.21294008149452215,0.2522202907022495,0.16277892790792295,WEE1,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1/19,274/21728,0.2143334321144098,0.25337866974765505,0.1635265271537929,LRP1,1
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,1/19,276/21728,0.21572444566058702,0.2545298101604605,0.16426945470235071,ITGA7,1
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,1/19,279/21728,0.21780659206447006,0.2564903883384686,0.16553478039445602,SLC20A2,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,1/19,282/21728,0.21988350085478647,0.25843725533992246,0.16679125711325454,SLC3A2,1
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,1/19,283/21728,0.2205746420225454,0.25875102237260134,0.16699375732071253,IRS2,1
REACTOME_SENSORY_PERCEPTION,REACTOME_SENSORY_PERCEPTION,1/19,284/21728,0.22126520307647757,0.2590629057133423,0.16719504182362385,LRP1,1
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,1/19,285/21728,0.22195518447647522,0.25937291672538293,0.16739511795563974,IRS2,1
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,1/19,286/21728,0.22264458668208742,0.25968106668465263,0.16759399299406402,GLUL,1
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,1/19,289/21728,0.2247093227229653,0.2610908321162073,0.16850383297922614,SCRN1,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,1/19,289/21728,0.2247093227229653,0.2610908321162073,0.16850383297922614,IRS2,1
BROWNE_HCMV_INFECTION_14HR_DN,BROWNE_HCMV_INFECTION_14HR_DN,1/19,291/21728,0.22608292585460976,0.26178693614596077,0.16895308734873055,ZFP36L2,1
REACTOME_CELL_CYCLE_CHECKPOINTS,REACTOME_CELL_CYCLE_CHECKPOINTS,1/19,292/21728,0.22676886252526174,0.26178693614596077,0.16895308734873055,WEE1,1
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,1/19,293/21728,0.2274542232087856,0.26178693614596077,0.16895308734873055,SLC3A2,1
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,1/19,293/21728,0.2274542232087856,0.26178693614596077,0.16895308734873055,SLC3A2,1
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,1/19,293/21728,0.2274542232087856,0.26178693614596077,0.16895308734873055,CHSY1,1
WANG_SMARCE1_TARGETS_UP,WANG_SMARCE1_TARGETS_UP,1/19,295/21728,0.22882321844135978,0.262866597456176,0.16964988343159593,MCC,1
MUELLER_PLURINET,MUELLER_PLURINET,1/19,299/21728,0.2315543171379022,0.2655040102521059,0.1713520273240511,WEE1,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,DAZARD_RESPONSE_TO_UV_NHEK_DN,1/19,300/21728,0.23223565868320917,0.26578565065057713,0.17153379351736986,WEE1,1
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,1/19,301/21728,0.23291642788635558,0.2660655824169979,0.17171445698698404,ITGA7,1
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,1/19,303/21728,0.2342762510821932,0.26711871618717353,0.17239413262123027,IRS2,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1/19,307/21728,0.23698904932525822,0.26970768673210355,0.17406501266230676,IRS2,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,1/19,309/21728,0.23834203161356682,0.2707423450358953,0.17473276452704892,IRS2,1
BORCZUK_MALIGNANT_MESOTHELIOMA_UP,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,1/19,311/21728,0.23969274083143677,0.271770579753116,0.17539637071210595,WEE1,1
BRUINS_UVC_RESPONSE_EARLY_LATE,BRUINS_UVC_RESPONSE_EARLY_LATE,1/19,314/21728,0.24171455054009017,0.27355450061123376,0.1765476846050068,LRP1,1
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,1/19,315/21728,0.24238735447862314,0.273804921408055,0.17670930216844277,CHSY1,1
PASINI_SUZ12_TARGETS_DN,PASINI_SUZ12_TARGETS_DN,1/19,316/21728,0.2430595928508693,0.273804921408055,0.17670930216844277,IRS2,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,1/19,317/21728,0.24373126610585882,0.273804921408055,0.17670930216844277,GLUL,1
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,1/19,317/21728,0.24373126610585882,0.273804921408055,0.17670930216844277,ITGA7,1
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,1/19,321/21728,0.2464123169221064,0.2762836793397873,0.17830905275768846,IRS2,1
SHEN_SMARCA2_TARGETS_DN,SHEN_SMARCA2_TARGETS_DN,1/19,322/21728,0.24708117131452423,0.2762836793397873,0.17830905275768846,CLCF1,1
JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,1/19,323/21728,0.24774946327682568,0.2762836793397873,0.17830905275768846,SCRN1,1
LEI_MYB_TARGETS,LEI_MYB_TARGETS,1/19,323/21728,0.24774946327682568,0.2762836793397873,0.17830905275768846,ZFP36L2,1
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,1/19,324/21728,0.248417193255697,0.27652278811309333,0.1784633697226867,ZFP36L2,1
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1/19,327/21728,0.2504170157535821,0.27824112861509126,0.17957235910620215,IRS2,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,1/19,333/21728,0.25440154734926035,0.28215444342372514,0.18209794968157586,PCSK5,1
WONG_EMBRYONIC_STEM_CELL_CORE,WONG_EMBRYONIC_STEM_CELL_CORE,1/19,335/21728,0.25572525953529146,0.2831078190862573,0.18271324303409878,WEE1,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,1/19,336/21728,0.2563862804331938,0.28332541859465254,0.18285367826471108,SLC20A2,1
BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,1/19,339/21728,0.25836600765381745,0.2849968619689487,0.18393240099462785,IRS2,1
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,1/19,341/21728,0.259683050656189,0.285932600903024,0.1845363118856445,SLC3A2,1
JOHNSTONE_PARVB_TARGETS_2_DN,JOHNSTONE_PARVB_TARGETS_2_DN,1/19,342/21728,0.2603407409370855,0.28614027382274265,0.18467034065522991,WEE1,1
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,1/19,343/21728,0.26099787765840776,0.28634659239501575,0.18480349535070903,CLCF1,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,1/19,345/21728,0.2623104921822079,0.28727001836830673,0.1853994596544378,ITGA7,1
MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,1/19,350/21728,0.26558237196249546,0.29033198368659896,0.18737560293147199,CLCF1,1
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,1/19,354/21728,0.268189972280807,0.29265810928674824,0.18887684706340613,SLC20A2,1
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,1/19,357/21728,0.2701399138325149,0.29373502217082725,0.18957186935615084,CHSY1,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,1/19,357/21728,0.2701399138325149,0.29373502217082725,0.18957186935615084,ACTN4,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,1/19,359/21728,0.27143713917436607,0.29462038237787064,0.1901432666252349,PCSK5,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,1/19,366/21728,0.2759602477731312,0.2989977817790587,0.1929683699488662,WEE1,1
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,1/19,371/21728,0.2791747382890557,0.3014098944359716,0.19452510874728804,WEE1,1
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,1/19,371/21728,0.2791747382890557,0.3014098944359716,0.19452510874728804,SCRN1,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,1/19,375/21728,0.2817365913512997,0.3036383758379732,0.19596333488076267,GLUL,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1/19,382/21728,0.2861990911052529,0.307903784081489,0.19871616090850197,SCRN1,1
VECCHI_GASTRIC_CANCER_EARLY_DN,VECCHI_GASTRIC_CANCER_EARLY_DN,1/19,384/21728,0.2874692587090999,0.3081832123243426,0.19889649941208654,GLUL,1
WANG_TUMOR_INVASIVENESS_UP,WANG_TUMOR_INVASIVENESS_UP,1/19,384/21728,0.2874692587090999,0.3081832123243426,0.19889649941208654,GLUL,1
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,1/19,386/21728,0.2887372848796488,0.3089995504852382,0.19942335096027455,ITGA7,1
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,1/19,389/21728,0.29063531640620177,0.31048606481222957,0.20038272345086086,CHSY1,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,1/19,398/21728,0.29630066241104247,0.31598497215163623,0.20393162999950296,LRP1,1
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,1/19,399/21728,0.296927492575796,0.3161008210667287,0.20400639703012347,GLUL,1
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,1/19,400/21728,0.2975537937451457,0.3162157041542489,0.20408054073112872,IRS2,1
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,1/19,401/21728,0.29817956634074005,0.3163296269006112,0.20415406464336253,WDR41,1
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,1/19,408/21728,0.3025452097968717,0.3204037812084926,0.2067834584503473,CLCF1,1
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,1/19,410/21728,0.30378780329772903,0.3207065131242631,0.20697883677044768,WEE1,1
REACTOME_NEURONAL_SYSTEM,REACTOME_NEURONAL_SYSTEM,1/19,411/21728,0.3044083132769645,0.3207065131242631,0.20697883677044768,GLUL,1
YAGI_AML_WITH_INV_16_TRANSLOCATION,YAGI_AML_WITH_INV_16_TRANSLOCATION,1/19,411/21728,0.3044083132769645,0.3207065131242631,0.20697883677044768,WEE1,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,1/19,412/21728,0.30502829929975095,0.3208056251256001,0.2070428020655297,SLC3A2,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,1/19,416/21728,0.30750301217904774,0.32285169953394,0.20836330565262048,GLUL,1
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,1/19,421/21728,0.31058466430931464,0.3251390548095723,0.2098395280393098,ITGA7,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,1/19,422/21728,0.31119943369862935,0.3251390548095723,0.2098395280393098,SLC3A2,1
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,1/19,423/21728,0.3118136837108193,0.3251390548095723,0.2098395280393098,ITGA7,1
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,1/19,423/21728,0.3118136837108193,0.3251390548095723,0.2098395280393098,GLUL,1
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,1/19,430/21728,0.3160989260095257,0.3290449571088919,0.21236033470013044,ZFP36L2,1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,1/19,432/21728,0.31731863012812767,0.3292629924583161,0.21250105121554827,IRS2,1
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,1/19,433/21728,0.31792770911139046,0.3292629924583161,0.21250105121554827,LRP1,1
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,1/19,433/21728,0.31792770911139046,0.3292629924583161,0.21250105121554827,LRP1,1
DELYS_THYROID_CANCER_UP,DELYS_THYROID_CANCER_UP,1/19,445/21728,0.3251966170729613,0.3362202312110278,0.2169911414545719,ACTN4,1
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,1/19,446/21728,0.32579903516606945,0.33627311582284664,0.21702527233433072,SLC3A2,1
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,1/19,449/21728,0.32760323397542634,0.33756414311657107,0.21785848063088453,WEE1,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1/19,452/21728,0.3294028581176017,0.3377990680068847,0.21801009738494376,LRP1,1
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,1/19,453/21728,0.3300017181333832,0.3377990680068847,0.21801009738494376,ZFP36L2,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,1/19,453/21728,0.3300017181333832,0.3377990680068847,0.21801009738494376,GLUL,1
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,1/19,454/21728,0.33060007147559045,0.3377990680068847,0.21801009738494376,WEE1,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1/19,454/21728,0.33060007147559045,0.3377990680068847,0.21801009738494376,CLCF1,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,1/19,456/21728,0.3317952597585061,0.3378883279677608,0.21806770433122097,IRS2,1
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,1/19,456/21728,0.3317952597585061,0.3378883279677608,0.21806770433122097,SMG6,1
MCCABE_BOUND_BY_HOXC6,MCCABE_BOUND_BY_HOXC6,1/19,458/21728,0.3329884262017474,0.33853823330510985,0.21848714280605883,CHSY1,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,1/19,466/21728,0.3377409381158175,0.3422291897851307,0.22086922688462277,CHSY1,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,1/19,466/21728,0.3377409381158175,0.3422291897851307,0.22086922688462277,CHSY1,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,1/19,467/21728,0.33833274143515735,0.3422603188647529,0.22088931709304158,WEE1,1
LIM_MAMMARY_STEM_CELL_UP,LIM_MAMMARY_STEM_CELL_UP,1/19,480/21728,0.3459807361265733,0.34941763085630745,0.22550853138957552,LRP1,1
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,1/19,482/21728,0.34714989109071104,0.3500188984550971,0.225896579848501,ACTN4,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,1/19,485/21728,0.3488999116150431,0.3512028813286738,0.22666070339417427,ZFP36L2,1
LIU_PROSTATE_CANCER_DN,LIU_PROSTATE_CANCER_DN,1/19,491/21728,0.3523866289035118,0.3541282432144023,0.2285486850080871,SCRN1,1
SENESE_HDAC3_TARGETS_UP,SENESE_HDAC3_TARGETS_UP,1/19,495/21728,0.35470127182732447,0.3558556521481605,0.2296635270119276,WEE1,1
ZHENG_BOUND_BY_FOXP3,ZHENG_BOUND_BY_FOXP3,1/19,496/21728,0.3552787067557509,0.3558556521481605,0.2296635270119276,ZFP36L2,1
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,1/19,497/21728,0.3558556521481605,0.3558556521481605,0.2296635270119276,IRS2,1
